To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RPS2andSNORA64andSNORA10TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
798 representative clones for gene RPS2andSNORA64andSNORA10 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BU184775 hepatocellular carcinoma, cell line, Liver .a 1 to 1022 2 to 1035   tiling clone,   1035/1086
(95 %)
38 diff
(96.6 %id)
BG393821 embryonal carcinoma, cell line, testis .a 2 to 830 1 to 832       828/832
(99 %)
20 diff
(97.6 %id)
BM553683 duodenal adenocarcinoma, cell line, small intestine .a 6 to 816 1 to 827       827/1019
(81 %)
27 diff
(97.4 %id)
TI_154194169   .a 7 to 830 48 to 861       814/993
(81 %)
13 diff
(98.7 %id)
BE745564 adenocarcinoma cell line, ovary .a 13 to 843 1 to 828       826/950
(86 %)
22 diff
(97.7 %id)
BC063508 Ovary, adenocarcinoma .a 170 to 1100 506 to 1436 exact tiling clone, AAA   936/1436
(65 %)
7 diff
(99.6 %id)
CR620130 neuroblastoma .a 172 to 1100 1 to 929 exact     929/929
(100 %)
0 diff
(100 %id)
BC071923 Brain, astrocytoma, grade IV .a 173 to 1100 1 to 929 exact available from MGC, AAA   930/929
(100 %)
9 diff
(99.1 %id)
TI_154102069   .a 173 to 1100 973 to 59 A2Q D3M D4T A5P G6C ... AAA   915/974
(93 %)
37 diff
(96.3 %id)
TI_154194278   .a 173 to 1100 48 to 972 D3V A226S A239G K246X T247D ...     925/1046
(88 %)
20 diff
(98.1 %id)
TI_154194737   .a 173 to 1099 51 to 973 G15D R200X G228X T232N G234X ... AAA   924/923
(100 %)
25 diff
(97.3 %id)
BC075830 Brain, astrocytoma, grade IV .a 176 to 1100 6 to 930 exact available from MGC, AAA   926/930
(99 %)
7 diff
(99.3 %id)
BC106060 Uterus, leiomyosarcoma .a 176 to 1108 6 to 938 S245F AAA   934/938
(99 %)
8 diff
(99.2 %id)
CR593005 Neuroblastoma Cot 25-normalized .a 176 to 1100 1 to 925 exact     925/925
(100 %)
0 diff
(100 %id)
CR605226 neuroblastoma .a 176 to 1100 1 to 925 exact     925/925
(100 %)
0 diff
(100 %id)
CR606602 placenta .a 176 to 1100 1 to 925 exact     925/925
(100 %)
0 diff
(100 %id)
CR607747 thymus .a 176 to 1069 1 to 894 exact     894/894
(100 %)
0 diff
(100 %id)
CR612811 fetal brain .a 176 to 1099 1 to 924 exact     924/924
(100 %)
0 diff
(100 %id)
BC035427.
matches multiple genes
cervix, Placenta, choriocarcinoma .a 176 to 1100 1 to 925 exact available from MGC, AAA also hits gene SEC31A 925/925
(100 %)
4 diff
(99.6 %id)
BQ420968 large cell carcinoma, lung .a 176 to 1070 96 to 1007 T202H G203W I204H V205R S206L ...     913/1188
(76 %)
40 diff
(96.7 %id)
TI_57232811   .a 176 to 1010 36 to 877       843/879
(95 %)
17 diff
(98.1 %id)
TI_57238341   .a 176 to 1080 39 to 953 A154G I155H I156H L157P A158G ...     916/955
(95 %)
36 diff
(96.3 %id)
TI_149312304   .a 176 to 1102 1002 to 88 A2R D3M D4T A5P G6C ... AAA   915/954
(95 %)
32 diff
(96.7 %id)
TI_154107131   .a 176 to 1100 1001 to 95 A2R D3M D4T A5R G6A ... AAA   907/967
(93 %)
34 diff
(96.5 %id)
TI_154126714   .a 176 to 1100 1001 to 89 A2R D3M D4T A5P G6C ... AAA   913/968
(94 %)
35 diff
(96.4 %id)
BC071922 Brain, astrocytoma, grade IV .a 177 to 1100 1 to 924 exact available from MGC, AAA   924/924
(100 %)
4 diff
(99.6 %id)
TI_57192362   .a 177 to 1047 59 to 937       879/879
(100 %)
17 diff
(98.1 %id)
TI_154034774   .a 177 to 1100 991 to 81 A2P D3M D4T A5P G6C ... AAA   911/940
(96 %)
30 diff
(96.9 %id)
CR610190 thymus .a 178 to 1100 1 to 923 exact     923/923
(100 %)
0 diff
(100 %id)
BC008329 Placenta, choriocarcinoma .a 178 to 1102 1 to 925 exact available from MGC, AAA   925/925
(100 %)
4 diff
(99.6 %id)
BG822108 adenocarcinoma cell line, colon .a 178 to 1062 1 to 887       887/887
(100 %)
20 diff
(97.8 %id)
BI195937 brain, neuroblastoma .a 178 to 1064 1 to 873 G201A T202L G203A I204S V205S ...     874/911
(95 %)
35 diff
(96.2 %id)
BU187460 eye, retinoblastoma .a 178 to 1023 11 to 867       857/879
(97 %)
31 diff
(96.5 %id)
BQ431792 eye, retinoblastoma .a 178 to 1005 11 to 843       833/946
(88 %)
27 diff
(97.2 %id)
TI_57190316   .a 178 to 994 56 to 871       816/818
(99 %)
8 diff
(99.1 %id)
TI_57192097   .a 178 to 992 119 to 935       817/817
(100 %)
2 diff
(99.8 %id)
TI_57193014   .a 178 to 1084 54 to 971 T230N A231C T232H L233P N235A ...     918/918
(100 %)
24 diff
(97.4 %id)
TI_154015747   .a 178 to 1100 998 to 88 A5X G6V A7Q A8R G10P ... AAA   911/1040
(87 %)
29 diff
(97.3 %id)
TI_154190241   .a 178 to 991 50 to 863   AAA   814/918
(88 %)
5 diff
(99.5 %id)
TI_154192027   .a 178 to 1100 50 to 970 R200X G234X A237X A243X K246X ... AAA   921/921
(100 %)
13 diff
(98.6 %id)
TI_154192838   .a 178 to 1099 50 to 964 A243X K257E E258G T259D V260C ... AAA   915/915
(100 %)
18 diff
(98.1 %id)
TI_154193447   .a 178 to 1099 50 to 965 L255S W256G K257R E258R T259L ... AAA   916/916
(100 %)
13 diff
(98.6 %id)
TI_154194259   .a 178 to 1081 50 to 952 P199L R200X A239G P265A F269V ...     903/1040
(86 %)
19 diff
(98.2 %id)
TI_154194525   .a 178 to 1085 46 to 940 P181X T232N G234X T247D D254T ...     896/1064
(84 %)
59 diff
(94.5 %id)
TI_154194780   .a 178 to 1094 50 to 959 A231G Y248T S249A Y250T L251*     910/1041
(87 %)
20 diff
(98.1 %id)
BC006559 Colon, adenocarcinoma .a 179 to 1100 9 to 930 exact available from MGC, AAA   922/922
(100 %)
0 diff
(100 %id)
BC018993 Brain, neuroblastoma .a 179 to 1100 4 to 925 exact available from MGC, AAA   922/922
(100 %)
0 diff
(100 %id)
BC032129 Muscle, rhabdomyosarcoma .a 179 to 1103 9 to 933 T202I available from MGC, AAA   925/925
(100 %)
4 diff
(99.6 %id)
CR591765 fetal brain .a 179 to 1079 1 to 901 exact     901/901
(100 %)
0 diff
(100 %id)
CR607612 placenta .a 179 to 1073 1 to 895 exact     895/895
(100 %)
0 diff
(100 %id)
CR609604 thymus .a 179 to 1069 1 to 891 exact     891/891
(100 %)
0 diff
(100 %id)
CR613584 T cells (Jurkat cell line) .a 179 to 1100 1 to 921 exact     921/921
(100 %)
1 diff
(99.9 %id)
BI092919 cervix .a 179 to 1081 1 to 900 Y223T T224P S225Q A226P R227G ...     900/900
(100 %)
14 diff
(98.5 %id)
BM811502 astrocytoma grade IV, cell line, brain .a 179 to 1044 2 to 875       874/1051
(83 %)
15 diff
(98.6 %id)
BM916962 blood, natural killer cells, cell line .a 179 to 1068 1 to 900 A237P S249G E258G T259N V260C ...     900/1080
(83 %)
27 diff
(97.5 %id)
BM562587 duodenal adenocarcinoma, cell line, small intestine .a 179 to 1052 1 to 883       883/1024
(86 %)
24 diff
(97.7 %id)
BM559900 brain, medulla .a 179 to 1033 17 to 876       860/1051
(81 %)
38 diff
(96.4 %id)
BQ277679 ovary, teratocarcinoma, cell line .a 179 to 1106 1 to 935 R227P C229L T230H A231C T232H ...     935/1063
(87 %)
37 diff
(96.6 %id)
BQ227404 large cell carcinoma, lung .a 179 to 1016 1 to 843       843/899
(93 %)
14 diff
(98.5 %id)
BQ425340 eye, retinoblastoma .a 179 to 1075 2 to 902 G234X S245F K246*     901/911
(98 %)
9 diff
(99.1 %id)
BQ649849 hepatocellular carcinoma, cell line, Liver .a 179 to 1024 1 to 858       858/1028
(83 %)
16 diff
(98.5 %id)
BQ950015 large cell carcinoma, lung .a 179 to 1065 2 to 893 A237P A239G T240H F241L D242*     892/910
(98 %)
14 diff
(98.5 %id)
BQ922168 epidermoid carcinoma, cell line, lung .a 179 to 1033 2 to 857       856/959
(89 %)
48 diff
(95.0 %id)
BU527425 epidermoid carcinoma, cell line, lung .a 179 to 1021 2 to 854       853/878
(97 %)
16 diff
(98.2 %id)
BU556913 ovary, teratocarcinoma, cell line .a 179 to 1091 1 to 917 R200X G234X T276D A287G P288S ...     917/918
(99 %)
14 diff
(98.5 %id)
TI_57232707   .a 179 to 1031 30 to 874       845/907
(93 %)
29 diff
(96.9 %id)
TI_57187165   .a 179 to 1044 53 to 926       874/875
(99 %)
12 diff
(98.7 %id)
TI_57189274   .a 179 to 1080 54 to 954 V128C A129C I130Y G131R D132G ...     901/980
(91 %)
31 diff
(96.9 %id)
TI_57191304   .a 179 to 1012 66 to 902       839/852
(98 %)
20 diff
(97.7 %id)
TI_154189887   .a 179 to 1100 47 to 963 R200X G228X G234C A239G D254E ...     917/1022
(89 %)
23 diff
(97.8 %id)
TI_154190214   .a 179 to 1099 41 to 959 K257E K263X D271X K275X T293P AAA   919/920
(99 %)
9 diff
(99.1 %id)
BM810601 astrocytoma grade IV, cell line, brain .a 181 to 1070 1 to 901 R227P N235Q F236L A237R K238Q ...     901/1107
(81 %)
22 diff
(98.1 %id)
BQ685294 ductal carcinoma, cell line, Pancreas .a 181 to 1044 1 to 869       869/887
(97 %)
12 diff
(98.7 %id)
BQ691527 ductal carcinoma, cell line, Pancreas .a 181 to 1097 1 to 920 T262P V274C K275Q V290G A291V ...     920/938
(98 %)
12 diff
(98.8 %id)
BQ668473 epidermoid carcinoma, cell line, salivary gland .a 181 to 1098 1 to 920 D254X H277P T278P R279Q V280S ...     920/964
(95 %)
13 diff
(98.7 %id)
BQ671451 epidermoid carcinoma, cell line, salivary gland .a 181 to 1057 1 to 891       891/971
(91 %)
33 diff
(96.7 %id)
BQ652509 hepatocellular carcinoma, cell line, Liver .a 181 to 1065 1 to 897 C229L T230H A231C T232H L233P ...     897/900
(99 %)
36 diff
(96.0 %id)
BU849973 ovary, teratocarcinoma, cell line .a 181 to 1095 1 to 918 G234X N235Q F236L A237S K238P ...     918/918
(100 %)
13 diff
(98.6 %id)
TI_149277906   .a 181 to 1100 997 to 92 A2P D3M D4T A5P G6C ... AAA   908/1073
(84 %)
34 diff
(96.9 %id)
CR607006 B cells (Ramos cell line) Cot 25-normalized .a 182 to 1100 1 to 919 exact     919/919
(100 %)
0 diff
(100 %id)
CR617837 Neuroblastoma Cot 25-normalized .a 182 to 1100 1 to 919 exact     919/919
(100 %)
0 diff
(100 %id)
BG774162 choriocarcinoma, placenta .a 182 to 1043 1 to 863       863/865
(99 %)
9 diff
(99.0 %id)
TI_1948074418   .a 182 to 1063 131 to 1015 D4A A5P G6V A7Q A8R ... fully sequenced,   885/1015
(87 %)
33 diff
(96.8 %id)
TI_1948074791   .a 182 to 1064 125 to 1010 A2E K183* fully sequenced,   886/1010
(87 %)
33 diff
(96.8 %id)
TI_1948153695.
matches multiple genes
  .a 182 to 1062 123 to 1000     also hits gene RPS2P46 878/1314
(66 %)
30 diff
(97.8 %id)
TI_1948218036   .a 182 to 1062 133 to 1016       884/1344
(65 %)
35 diff
(97.4 %id)
TI_154193755   .a 182 to 1099 51 to 965 S225L A226S G228X G234X K246X ... AAA   915/915
(100 %)
24 diff
(97.4 %id)
BQ924051 sciatic nerve .a 183 to 1040 1 to 868       868/919
(94 %)
28 diff
(97.0 %id)
BU848889 ovary, teratocarcinoma, cell line .a 183 to 1052 1 to 876       876/881
(99 %)
10 diff
(98.9 %id)
BU849849 ovary, teratocarcinoma, cell line .a 183 to 1033 1 to 852       852/895
(95 %)
17 diff
(98.2 %id)
TI_57171751.
matches multiple genes
  .a 183 to 1069 39 to 936   tiling clone, AAA also hits gene RPS2P5 894/1107
(80 %)
40 diff
(96.4 %id)
CR590936 T cells (Jurkat cell line) Cot10-normalized .a 184 to 1103 1 to 920   tiling clone,   920/920
(100 %)
0 diff
(100 %id)
TI_57186661   .a 184 to 1100 51 to 964       914/948
(96 %)
33 diff
(96.6 %id)
TI_57186781   .a 184 to 1086 30 to 943   AAA   914/958
(95 %)
39 diff
(96.0 %id)
TI_57187571   .a 184 to 1100 56 to 976       921/926
(99 %)
14 diff
(98.5 %id)
TI_57190026   .a 184 to 1045 81 to 954       874/899
(97 %)
28 diff
(96.9 %id)
TI_59394982   .a 184 to 981 100 to 901       802/802
(100 %)
8 diff
(99.1 %id)
TI_59395165   .a 184 to 992 57 to 876       820/1025
(80 %)
15 diff
(98.6 %id)
TI_154182647   .a 184 to 1012 75 to 905       831/838
(99 %)
21 diff
(97.5 %id)
TI_154189184   .a 184 to 1099 50 to 960   AAA   911/911
(100 %)
16 diff
(98.3 %id)
TI_154189335   .a 184 to 1100 50 to 960   AAA   911/911
(100 %)
15 diff
(98.4 %id)
TI_154189557   .a 184 to 1092 50 to 950       901/1019
(88 %)
20 diff
(98.1 %id)
TI_154189733   .a 184 to 1099 50 to 963   AAA   914/914
(100 %)
18 diff
(98.1 %id)
TI_154189993   .a 184 to 994 50 to 851       802/960
(83 %)
17 diff
(98.3 %id)
TI_154190540   .a 184 to 1100 50 to 960   AAA   911/911
(100 %)
25 diff
(97.3 %id)
TI_154191084   .a 184 to 1100 48 to 959       912/995
(91 %)
11 diff
(98.9 %id)
TI_154192411   .a 184 to 1099 50 to 961   AAA   912/912
(100 %)
17 diff
(98.2 %id)
TI_154192464   .a 184 to 1099 51 to 960   AAA   910/910
(100 %)
16 diff
(98.3 %id)
TI_154192633   .a 184 to 1080 51 to 946       896/1015
(88 %)
22 diff
(97.9 %id)
TI_154192700   .a 184 to 1100 49 to 965   AAA   917/917
(100 %)
19 diff
(98.0 %id)
TI_154193103   .a 184 to 1100 49 to 959   AAA   911/911
(100 %)
16 diff
(98.3 %id)
TI_154193469   .a 184 to 1100 50 to 961   AAA   912/912
(100 %)
12 diff
(98.7 %id)
TI_154194266   .a 184 to 1070 45 to 928       884/1023
(86 %)
14 diff
(98.7 %id)
TI_154194728   .a 184 to 1100 50 to 960       911/1045
(87 %)
30 diff
(97.2 %id)
CR594414 fetal brain .a 185 to 1079 1 to 895       895/895
(100 %)
0 diff
(100 %id)
BG684078 B-cells, primary B-cells from tonsils (cell line) .a 185 to 1050 1 to 868       868/868
(100 %)
5 diff
(99.5 %id)
BI857435 breast, mammary adenocarcinoma, cell line .a 185 to 1100 1 to 920       920/925
(99 %)
14 diff
(98.5 %id)
BQ948810 epidermoid carcinoma, cell line, lung .a 185 to 1076 1 to 896       896/896
(100 %)
8 diff
(99.2 %id)
BU844568 ovary, teratocarcinoma, cell line .a 185 to 1041 1 to 862       862/920
(93 %)
12 diff
(98.7 %id)
CR613101 Placenta Cot 25-normalized .a 186 to 1100 1 to 915       915/915
(100 %)
0 diff
(100 %id)
BC019021 Colon, adenocarcinoma .a 186 to 1100 1 to 915   available from MGC, AAA   915/915
(100 %)
1 diff
(99.9 %id)
BM807252 duodenal adenocarcinoma, cell line, small intestine .a 186 to 1101 1 to 918       918/1017
(90 %)
20 diff
(98.1 %id)
BU165231 eye, retinoblastoma .a 186 to 1048 1 to 870       870/873
(99 %)
13 diff
(98.6 %id)
BQ685678 ductal carcinoma, cell line, Pancreas .a 186 to 1024 1 to 847       847/906
(93 %)
24 diff
(97.4 %id)
BQ948432 epidermoid carcinoma, cell line, lung .a 186 to 1061 1 to 882       882/884
(99 %)
12 diff
(98.7 %id)
BQ439607 large cell carcinoma, lung .a 187 to 1019 1 to 841       841/1096
(76 %)
20 diff
(98.2 %id)
TI_57190604   .a 187 to 1045 90 to 958       869/878
(98 %)
23 diff
(97.4 %id)
TI_57227926   .a 187 to 1079 54 to 940       887/916
(96 %)
21 diff
(97.8 %id)
BQ685243 ductal carcinoma, cell line, Pancreas .a 188 to 1024 1 to 845       845/865
(97 %)
17 diff
(98.1 %id)
TI_57186020   .a 188 to 997 54 to 868       815/815
(100 %)
9 diff
(98.9 %id)
BM471933 eye, retinoblastoma .a 189 to 1098 1 to 915       915/1043
(87 %)
19 diff
(98.2 %id)
BE299735 muscle, rhabdomyosarcoma .a 190 to 587 1 to 397   fully sequenced,   397/397
(100 %)
2 diff
(99.5 %id)
BQ688730 ductal carcinoma, cell line, Pancreas .a 190 to 1022 1 to 842       842/961
(87 %)
25 diff
(97.4 %id)
BU556546 ovary, teratocarcinoma, cell line .a 190 to 1048 1 to 868       868/900
(96 %)
20 diff
(97.8 %id)
TI_57202645   .a 190 to 1014 56 to 884       829/886
(93 %)
26 diff
(97.1 %id)
BQ277854 ovary, teratocarcinoma, cell line .a 191 to 1106 1 to 933       933/1092
(85 %)
16 diff
(98.6 %id)
TI_154192580   .a 191 to 1100 51 to 955   AAA   905/905
(100 %)
18 diff
(98.1 %id)
BF313752 brain, neuroblastoma .a 192 to 1057 1 to 864       864/868
(99 %)
26 diff
(97.1 %id)
CR622407 Placenta Cot 25-normalized .a 193 to 1099 1 to 907       907/907
(100 %)
0 diff
(100 %id)
BC020336 Ovary, adenocarcinoma .a 193 to 1100 930 to 23   available from MGC, AAA Submitted on the opposite strand 908/934
(97 %)
1 diff
(99.9 %id)
CN405553 embryonic stem cells, DMSO-treated H9 cellline .a 194 to 1100 1 to 909       909/916
(99 %)
3 diff
(99.7 %id)
TI_149296235   .a 195 to 1100 979 to 85   AAA   895/972
(92 %)
34 diff
(96.6 %id)
BE561308 Burkitt lymphoma, lymph .a 196 to 1096 1 to 894       894/1020
(87 %)
43 diff
(95.8 %id)
BM910611 astrocytoma grade IV, cell line, brain .a 207 to 1097 1 to 899       899/1046
(85 %)
8 diff
(99.3 %id)
BU540621 large cell carcinoma, lung .a 209 to 1070 1 to 869       869/883
(98 %)
21 diff
(97.7 %id)
CR596231 thymus .a 212 to 1095 1 to 884       884/884
(100 %)
0 diff
(100 %id)
BM423994 amelanotic melanoma, cell line, skin .a 244 to 1100 926 to 41   AAA Submitted on the opposite strand 886/1056
(83 %)
36 diff
(96.6 %id)
BU528032 epidermoid carcinoma, cell line, lung .a 244 to 1100 899 to 30   AAA Submitted on the opposite strand 868/874
(99 %)
20 diff
(97.8 %id)
TI_154052705   .a 247 to 1100 935 to 96   AAA   842/958
(87 %)
23 diff
(97.6 %id)
TI_154059770   .a 248 to 1102 930 to 82   AAA   849/992
(85 %)
18 diff
(98.2 %id)
TI_154102971   .a 249 to 1100 924 to 81   AAA   846/973
(86 %)
20 diff
(98.0 %id)
TI_154127387   .a 251 to 1104 927 to 81   AAA   847/980
(86 %)
15 diff
(98.5 %id)
TI_154131809   .a 255 to 1100 932 to 91   AAA   844/987
(85 %)
28 diff
(97.2 %id)
BM909653 astrocytoma grade IV, cell line, brain .a 259 to 1100 1 to 846   AAA   846/846
(100 %)
10 diff
(98.9 %id)
TI_149296548   .a 259 to 1108 908 to 63   AAA   846/960
(88 %)
19 diff
(98.1 %id)
TI_149296148   .a 261 to 1102 908 to 78   AAA   831/937
(88 %)
18 diff
(98.1 %id)
TI_154102790   .a 261 to 1100 910 to 84   AAA   827/976
(84 %)
19 diff
(98.1 %id)
TI_154061678   .a 262 to 1100 932 to 101   AAA   832/961
(86 %)
19 diff
(98.1 %id)
TI_154031033   .a 263 to 1100 889 to 61   AAA   829/967
(85 %)
18 diff
(98.2 %id)
TI_154102785   .a 263 to 1100 914 to 90   AAA   825/960
(85 %)
21 diff
(97.9 %id)
TI_154115365   .a 263 to 1100 914 to 86   AAA   831/974
(85 %)
23 diff
(97.7 %id)
TI_154115409   .a 263 to 1100 918 to 95   AAA   826/958
(86 %)
29 diff
(97.0 %id)
BQ896937 melanotic melanoma, cell line, skin .a 265 to 1100 863 to 18   AAA Submitted on the opposite strand 843/848
(99 %)
22 diff
(97.5 %id)
TI_149279948   .a 266 to 1100 880 to 58   AAA   825/957
(86 %)
26 diff
(97.3 %id)
TI_154102714   .a 269 to 1100 912 to 85   AAA   828/979
(84 %)
15 diff
(98.5 %id)
TI_154102779   .a 279 to 1100 893 to 86   AAA   808/941
(85 %)
23 diff
(97.6 %id)
TI_149286410   .a 281 to 1100 903 to 88   AAA   816/1057
(77 %)
17 diff
(98.4 %id)
AB082925   .a 306 to 1100 1 to 795   AAA   795/795
(100 %)
3 diff
(99.7 %id)
TI_59394486   .a 306 to 1081 92 to 868       777/777
(100 %)
3 diff
(99.7 %id)
TI_154141828   .a 306 to 986 81 to 761       681/681
(100 %)
3 diff
(99.6 %id)
TI_154101379   .a 307 to 1100 875 to 87   AAA   789/795
(99 %)
15 diff
(98.2 %id)
TI_154060926   .a 308 to 1100 876 to 94   AAA   785/962
(81 %)
19 diff
(98.1 %id)
BU742427 eye, fetal eye .a 308 to 1100 807 to 19   AAA   791/828
(95 %)
9 diff
(99.0 %id)
TI_57188602   .a 317 to 1100 59 to 846       788/818
(96 %)
14 diff
(98.3 %id)
CX164921 human embryonic stem cells differentiated toan early endodermal cell type .a 359 to 854 372 to 867       867/867
(100 %)
5 diff
(99.5 %id)
TI_1948074419   .a 418 to 1062 772 to 128   fully sequenced,   645/772
(83 %)
1 diff
(99.9 %id)
TI_1948074792   .a 418 to 1062 773 to 129   fully sequenced,   645/773
(83 %)
2 diff
(99.8 %id)
W05673 lung .a 428 to 682 1 to 257       257/262
(98 %)
7 diff
(97.4 %id)
BE299699 muscle, rhabdomyosarcoma .a 526 to 1051 526 to 1   fully sequenced,   526/526
(100 %)
0 diff
(100 %id)
TI_59385736   .a 559 to 1108 59 to 608   AAA   550/594
(92 %)
1 diff
(99.9 %id)
TI_59385761   .a 559 to 1108 63 to 612       550/1149
(47 %)
4 diff
(99.7 %id)
TI_59386084   .a 559 to 1050 100 to 593       494/968
(51 %)
8 diff
(99.2 %id)
TI_59394218   .a 565 to 1100 98 to 635       538/816
(65 %)
4 diff
(99.6 %id)
TI_57176069   .a 566 to 1100 61 to 600       536/971
(55 %)
5 diff
(99.5 %id)
CR608509 B cells (Ramos cell line) .a 570 to 1100 1 to 531       531/531
(100 %)
0 diff
(100 %id)
TI_154142649   .a 572 to 1097 85 to 610       526/637
(82 %)
9 diff
(98.6 %id)
AA074604   .a 582 to 1100 555 to 24   AAA   528/532
(99 %)
20 diff
(96.3 %id)
TI_44385111   .a 622 to 1100 81 to 558       478/963
(49 %)
2 diff
(99.8 %id)
TI_59393586   .a 622 to 1100 100 to 577   AAA   478/478
(100 %)
1 diff
(99.8 %id)
TI_154093053   .a 642 to 1100 584 to 126   AAA   459/459
(100 %)
0 diff
(100 %id)
N74974 lung .a 805 to 1108 307 to 1       307/309
(99 %)
4 diff
(98.8 %id)
AK312173 brain .b 1 to 907 1 to 907 exact tiling clone,   907/907
(100 %)
3 diff
(99.7 %id)
BC066321 testis .b 3 to 944 1 to 942 exact available from MGC, AAA   942/942
(100 %)
2 diff
(99.8 %id)
NM_002952.3   .b 3 to 944 1 to 942 exact RefSeq, AAA   942/942
(100 %)
0 diff
(100 %id)
BM742454 Ascites, stomach .b 3 to 566 1 to 564       564/564
(100 %)
0 diff
(100 %id)
BM761940 myeloma .b 3 to 578 1 to 576       576/576
(100 %)
0 diff
(100 %id)
BM848231 myeloma .b 3 to 496 1 to 494       494/494
(100 %)
0 diff
(100 %id)
BM781800 myeloma .b 3 to 503 1 to 501       501/501
(100 %)
0 diff
(100 %id)
BM846536 myeloma .b 3 to 458 1 to 456       456/456
(100 %)
0 diff
(100 %id)
BM820336 stomach .b 3 to 496 1 to 494       494/494
(100 %)
0 diff
(100 %id)
X17206 colon .b 3 to 935 9 to 934 P14W G15W G16P P17W G18D ...     926/934
(99 %)
16 diff
(98.3 %id)
BM826739 stomach .b 5 to 513 1 to 509       509/509
(100 %)
0 diff
(100 %id)
BM763419 myeloma .b 8 to 460 1 to 453       453/453
(100 %)
0 diff
(100 %id)
BC103756 Lung, large cell carcinoma .b 10 to 944 21 to 955 exact tiling clone, AAA   935/935
(100 %)
1 diff
(99.9 %id)
BU175814 eye, retinoblastoma .b 10 to 875 8 to 882       875/884
(98 %)
20 diff
(97.8 %id)
BC068051 Primary B-Cells from Tonsils .b 14 to 944 1 to 931 exact available from MGC, AAA   931/931
(100 %)
0 diff
(100 %id)
BC105985 Cervix, carcinoma .b 14 to 944 1 to 931 exact AAA   931/931
(100 %)
1 diff
(99.9 %id)
BC071673 Testis, embryonal carcinoma .b 15 to 944 1 to 930 V274A available from MGC, AAA   930/930
(100 %)
3 diff
(99.7 %id)
AW248241 lung, small cell carcinoma .b 15 to 464 10 to 459   fully sequenced,   450/459
(98 %)
1 diff
(99.8 %id)
BG519781 brain, neuroblastoma .b 15 to 945 2 to 936 D254R L255P W256L K257E E258G ...     935/940
(99 %)
17 diff
(98.2 %id)
BC029979 Bone, osteosarcoma .b 15 to 944 1 to 930 exact available from MGC, AAA   930/930
(100 %)
1 diff
(99.9 %id)
BG332849 large cell carcinoma, lung .b 15 to 913 2 to 913 A231C T247D Y248L S249T Y250A ...     912/927
(98 %)
29 diff
(96.9 %id)
BG396091 eye, retinoblastoma .b 15 to 869 2 to 855       854/895
(95 %)
22 diff
(97.6 %id)
BG489483 large cell carcinoma, lung .b 15 to 933 2 to 922 P208T V209C P210A K211*     921/938
(98 %)
24 diff
(97.5 %id)
BG468526 adenocarcinoma cell line, colon .b 15 to 888 2 to 875       874/875
(99 %)
15 diff
(98.3 %id)
BG747494 adenocarcinoma cell line, colon .b 15 to 862 2 to 860       859/861
(99 %)
18 diff
(98.0 %id)
BG770425 melanotic melanoma, high MDR (cell line), skin .b 15 to 913 2 to 899 M216N A217G G218W I219Y D220R ...     898/949
(94 %)
22 diff
(97.7 %id)
BG822233 adenocarcinoma cell line, colon .b 15 to 913 2 to 899 G218W I219Y D220R D221*     898/970
(92 %)
41 diff
(95.8 %id)
BG823144 adenocarcinoma cell line, colon .b 15 to 924 2 to 911 D221R C222L Y223L T224H S225L ...     910/979
(92 %)
32 diff
(96.8 %id)
BG822834 adenocarcinoma cell line, colon .b 15 to 893 2 to 875   AAA   874/917
(95 %)
19 diff
(98.0 %id)
BI090523 cervix .b 15 to 855 1 to 844       844/847
(99 %)
12 diff
(98.6 %id)
BI084144 epidermoid carcinoma, cell line, salivary gland .b 15 to 323 2 to 310   fully sequenced,   309/310
(99 %)
0 diff
(100 %id)
BM910605 astrocytoma grade IV, cell line, brain .b 15 to 943 13 to 946 G234X K257E D271G H272P L273P ...     934/1090
(85 %)
14 diff
(98.8 %id)
BQ643510 hepatocellular carcinoma, cell line, Liver .b 15 to 867 13 to 869       857/1004
(85 %)
7 diff
(99.4 %id)
TI_57190746   .b 15 to 938 55 to 1004 L107W K108N I109D M110Y P111A ... AAA   946/977
(96 %)
47 diff
(95.2 %id)
AJ712763 bone marrow .b 16 to 508 1 to 493       493/493
(100 %)
0 diff
(100 %id)
BC073966 Skin, melanotic melanoma. .b 16 to 944 1 to 929 exact available from MGC, AAA   929/929
(100 %)
1 diff
(99.9 %id)
BG764948 melanotic melanoma, high MDR (cell line), skin .b 16 to 928 2 to 911 R227G G228A C229A T230L A231P ...     910/939
(96 %)
20 diff
(97.9 %id)
BI195870 brain, neuroblastoma .b 16 to 920 2 to 893 L107X T202H G203W I204H V205R ...     892/922
(96 %)
35 diff
(96.3 %id)
BG826335 muscle, rhabdomyosarcoma .b 16 to 920 2 to 906 L214P M215H M216D A217G G218W ...     905/980
(92 %)
27 diff
(97.3 %id)
BI225896 Burkitt lymphoma, lymph .b 16 to 914 2 to 893 G201A T202L G203A I204S V205S ...     892/898
(99 %)
15 diff
(98.4 %id)
BI859726 breast, mammary adenocarcinoma, cell line .b 16 to 912 1 to 890 I204H V205R S206L A207R P208T ...     890/948
(93 %)
26 diff
(97.3 %id)
BM557665 astrocytoma grade IV, cell line, brain .b 16 to 859 1 to 848       848/1035
(81 %)
14 diff
(98.7 %id)
BM799553 eye, retinoblastoma .b 16 to 946 1 to 932 G234X K257X H277P T278P R279E ... AAA   932/932
(100 %)
12 diff
(98.8 %id)
BM907302 large cell carcinoma, lung .b 16 to 859 1 to 847       847/964
(87 %)
8 diff
(99.2 %id)
BQ232741 large cell carcinoma, lung .b 16 to 946 1 to 932 G234S D254E W256L K257E V274L ... AAA   932/932
(100 %)
18 diff
(98.1 %id)
BU170726 eye, retinoblastoma .b 16 to 868 1 to 864       864/899
(96 %)
21 diff
(97.7 %id)
BU178873 eye, retinoblastoma .b 16 to 899 1 to 891       891/893
(99 %)
18 diff
(98.0 %id)
TI_57189780   .b 16 to 912 55 to 944 I204H V205R S206L A207R P208T ...     890/948
(93 %)
26 diff
(97.3 %id)
BM720245 eye, fetal eye .b 16 to 362 1 to 347   fully sequenced,   347/347
(100 %)
1 diff
(99.8 %id)
BM470764 eye, retinoblastoma .b 17 to 863 1 to 852       852/1003
(84 %)
17 diff
(98.4 %id)
BQ052600 blood, natural killer cells, cell line .b 17 to 888 1 to 877       877/1048
(83 %)
20 diff
(98.1 %id)
BQ053181 blood, natural killer cells, cell line .b 17 to 859 1 to 850       850/1012
(83 %)
16 diff
(98.5 %id)
BQ434986 eye, retinoblastoma .b 17 to 897 1 to 892       892/892
(100 %)
19 diff
(97.9 %id)
BQ673911 epidermoid carcinoma, cell line, salivary gland .b 17 to 859 1 to 854       854/925
(92 %)
25 diff
(97.3 %id)
BU844399 ovary, teratocarcinoma, cell line .b 17 to 859 1 to 851       851/925
(92 %)
13 diff
(98.6 %id)
BU556963 ovary, teratocarcinoma, cell line .b 17 to 884 1 to 882       882/921
(95 %)
31 diff
(96.7 %id)
TI_45133532   .b 17 to 836 98 to 916       819/824
(99 %)
12 diff
(98.6 %id)
BM557689 duodenal adenocarcinoma, cell line, small intestine .b 18 to 884 1 to 874       874/1009
(86 %)
14 diff
(98.7 %id)
BM927924 hepatocellular carcinoma, cell line, Liver .b 18 to 939 1 to 925 F241L D242*     925/991
(93 %)
23 diff
(97.7 %id)
BU162964 ductal carcinoma, cell line, Pancreas .b 18 to 945 1 to 932 G234X K238Q K263Q Q267* AAA   932/932
(100 %)
16 diff
(98.3 %id)
BU176645 eye, retinoblastoma .b 18 to 886 1 to 878       878/903
(97 %)
20 diff
(97.8 %id)
BQ686266 ductal carcinoma, cell line, Pancreas .b 18 to 944 1 to 931 K257X K263Q H272P L273P V274R ... AAA   931/931
(100 %)
12 diff
(98.8 %id)
BQ686039 ductal carcinoma, cell line, Pancreas .b 18 to 895 1 to 893       893/947
(94 %)
25 diff
(97.4 %id)
BQ685768 ductal carcinoma, cell line, Pancreas .b 18 to 896 1 to 881       881/886
(99 %)
16 diff
(98.2 %id)
BU845047 ovary, teratocarcinoma, cell line .b 18 to 896 1 to 880       880/911
(96 %)
7 diff
(99.3 %id)
TI_59383178   .b 18 to 943 101 to 1027 G201A T202L G203A I204S V205S ... AAA   927/927
(100 %)
31 diff
(96.7 %id)
BQ231082 large cell carcinoma, lung .b 19 to 944 1 to 937 V209C P210A K211*     937/1005
(93 %)
12 diff
(98.9 %id)
DR158623 human embryonic stem cells differentiated toan early endodermal cell type .b 19 to 859 1 to 841       841/841
(100 %)
0 diff
(100 %id)
TI_154189491   .b 19 to 946 50 to 967 P197X A226X G228X G234X K257E ... AAA   918/918
(100 %)
22 diff
(97.7 %id)
BC071924 Breast, adenocarcinoma .b 20 to 944 1 to 925 exact available from MGC, AAA   925/925
(100 %)
1 diff
(99.9 %id)
BE383645 brain, neuroblastoma .b 20 to 734 45 to 750       705/757
(93 %)
21 diff
(97.3 %id)
TI_154189879   .b 20 to 943 40 to 959 A239G T252D F261I K275R H277T ...     920/1024
(89 %)
20 diff
(98.1 %id)
BM887798 eye .b 21 to 510 1 to 490       490/490
(100 %)
0 diff
(100 %id)
BC013833.
matches multiple genes
brain, Brain, glioblastoma with EGFR amplification, glioblastoma with EGFR amplification .b 21 to 944 1 to 924 exact available from MGC, AAA also hits gene TTC36andTMEM25 924/924
(100 %)
2 diff
(99.8 %id)
BM552502 astrocytoma grade IV, cell line, brain .b 21 to 944 1 to 927 G234X K263S S264L Y266I Q267R ... AAA   927/927
(100 %)
7 diff
(99.3 %id)
BQ222710 large cell carcinoma, lung .b 21 to 873 1 to 873       873/1010
(86 %)
25 diff
(97.6 %id)
BU195177 eye, retinoblastoma .b 21 to 884 1 to 873       873/959
(91 %)
20 diff
(98.0 %id)
TI_57189072   .b 21 to 825 85 to 893       809/812
(99 %)
10 diff
(98.8 %id)
TI_57193103   .b 21 to 853 88 to 925       838/842
(99 %)
9 diff
(99.0 %id)
TI_59381935   .b 21 to 944 103 to 1024 N172E K173Q I174D G175R K176Q ... AAA   922/922
(100 %)
38 diff
(95.9 %id)
TI_154190797   .b 21 to 852 51 to 878       828/1012
(81 %)
21 diff
(98.0 %id)
BG468703 adenocarcinoma cell line, colon .b 22 to 680 1 to 658       658/659
(99 %)
2 diff
(99.7 %id)
CN405150 embryonic stem cells, DMSO-treated H9 cellline .b 23 to 602 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BM909095 astrocytoma grade IV, cell line, brain .b 23 to 734 2 to 714       713/1173
(60 %)
4 diff
(99.7 %id)
BU186236 large cell carcinoma, lung .b 23 to 734 2 to 716       715/936
(76 %)
10 diff
(99.0 %id)
BU175116 eye, retinoblastoma .b 23 to 734 2 to 716       715/814
(87 %)
10 diff
(98.8 %id)
BQ672111 epidermoid carcinoma, cell line, salivary gland .b 23 to 732 1 to 713       713/946
(75 %)
9 diff
(99.1 %id)
BU849914 ovary, teratocarcinoma, cell line .b 23 to 708 1 to 692       692/854
(81 %)
7 diff
(99.2 %id)
CD724190 eye, lacrimal gland .b 23 to 623 1 to 601       601/601
(100 %)
0 diff
(100 %id)
BM794882 Ascites, stomach .b 23 to 699 1 to 677       677/677
(100 %)
0 diff
(100 %id)
BM823779 Ascites, stomach .b 23 to 487 2 to 466       465/466
(99 %)
0 diff
(100 %id)
CN405396 embryonic stem cells, DMSO-treated H9 cellline .b 25 to 679 1 to 655       655/655
(100 %)
0 diff
(100 %id)
BQ051485 blood, natural killer cells, cell line .b 25 to 732 1 to 717       715/1128
(63 %)
13 diff
(98.9 %id)
BU859016 ovary, teratocarcinoma, cell line .b 25 to 734 1 to 716       716/938
(76 %)
10 diff
(99.0 %id)
CN405336 embryonic stem cells, DMSO-treated H9 cellline .b 26 to 498 1 to 473       473/473
(100 %)
0 diff
(100 %id)
CN405345 embryonic stem cells, DMSO-treated H9 cellline .b 26 to 681 1 to 656       656/656
(100 %)
1 diff
(99.9 %id)
CN405428 embryonic stem cells, DMSO-treated H9 cellline .b 26 to 533 1 to 508       508/508
(100 %)
0 diff
(100 %id)
CN405593 embryonic stem cells, DMSO-treated H9 cellline .b 26 to 622 1 to 597       597/597
(100 %)
0 diff
(100 %id)
CN405641 embryonic stem cells, cell lines H1, H7, andH9 .b 26 to 655 1 to 630       630/630
(100 %)
0 diff
(100 %id)
CN405119 embryonic stem cells, DMSO-treated H9 cellline .b 27 to 718 1 to 694       694/694
(100 %)
1 diff
(99.9 %id)
CN405251 embryonic stem cells, DMSO-treated H9 cellline .b 27 to 628 1 to 602       602/602
(100 %)
0 diff
(100 %id)
CN405419 embryonic stem cells, DMSO-treated H9 cellline .b 27 to 596 1 to 570       570/570
(100 %)
0 diff
(100 %id)
CN405488 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 27 to 600 1 to 574       574/574
(100 %)
0 diff
(100 %id)
CN405102 embryonic stem cells, DMSO-treated H9 cellline .b 28 to 525 1 to 498       498/498
(100 %)
0 diff
(100 %id)
CN405190 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 28 to 621 1 to 594       594/594
(100 %)
0 diff
(100 %id)
CN405346 embryonic stem cells, cell lines H1, H7, andH9 .b 28 to 650 1 to 623       623/623
(100 %)
0 diff
(100 %id)
CN405416 embryonic stem cells, DMSO-treated H9 cellline .b 28 to 496 1 to 469       469/469
(100 %)
0 diff
(100 %id)
CN405669 embryonic stem cells, DMSO-treated H9 cellline .b 28 to 558 1 to 531       531/531
(100 %)
0 diff
(100 %id)
BG335270 choriocarcinoma, placenta .b 28 to 734 1 to 703       703/1103
(63 %)
14 diff
(98.8 %id)
BM907549 large cell carcinoma, lung .b 28 to 946 942 to 16   AAA Submitted on the opposite strand 926/1011
(91 %)
28 diff
(97.3 %id)
ES308210 beard hair, skin .b 29 to 179 1 to 144       144/145
(99 %)
12 diff
(91.8 %id)
BM789442 Ascites, stomach .b 29 to 603 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BU077831 insulinoma, Pancreas .b 30 to 603 10 to 583       574/583
(98 %)
8 diff
(98.7 %id)
CN405647 embryonic stem cells, DMSO-treated H9 cellline .b 31 to 632 1 to 602       602/602
(100 %)
0 diff
(100 %id)
CN405712 embryonic stem cells, DMSO-treated H9 cellline .b 31 to 479 1 to 449       449/449
(100 %)
0 diff
(100 %id)
TI_154062184   .b 32 to 944 985 to 86   AAA   900/1006
(89 %)
36 diff
(96.5 %id)
BE382398 brain, neuroblastoma .b 33 to 712 1 to 677       677/679
(99 %)
7 diff
(99.0 %id)
BP422097 small intestine .b 34 to 545 1 to 512     Submitted on the opposite strand 512/512
(100 %)
0 diff
(100 %id)
AA158642 Pancreas .b 34 to 389 1 to 365       314/369
(85 %)
24 diff
(93.5 %id)
BE251926 eye, retinoblastoma .b 34 to 551 1 to 518       518/518
(100 %)
0 diff
(100 %id)
BE256564 eye, retinoblastoma .b 34 to 708 1 to 676       676/705
(95 %)
2 diff
(99.8 %id)
BE251774 eye, retinoblastoma .b 34 to 582 1 to 549       549/549
(100 %)
0 diff
(100 %id)
BE252142 eye, retinoblastoma .b 34 to 492 1 to 459       459/459
(100 %)
0 diff
(100 %id)
BE614871 adenocarcinoma, Pancreas .b 34 to 861 1 to 862       782/971
(80 %)
56 diff
(94.3 %id)
BE513930 Burkitt lymphoma, lymph .b 34 to 516 1 to 483       483/483
(100 %)
0 diff
(100 %id)
BE257303 eye, retinoblastoma .b 35 to 598 1 to 564       564/564
(100 %)
0 diff
(100 %id)
BE396601 Burkitt lymphoma, lymph .b 35 to 532 1 to 498       498/498
(100 %)
0 diff
(100 %id)
BE407375 choriocarcinoma, placenta .b 35 to 607 1 to 573       573/573
(100 %)
0 diff
(100 %id)
BE866812 adenocarcinoma, colon .b 35 to 734 1 to 701       701/767
(91 %)
4 diff
(99.5 %id)
BE788636 large cell carcinoma, lung .b 35 to 707 1 to 683       681/690
(98 %)
25 diff
(96.4 %id)
BE896751 melanotic melanoma, skin .b 35 to 739 1 to 703       701/768
(91 %)
15 diff
(98.1 %id)
TI_154144728   .b 35 to 543 76 to 597       522/564
(92 %)
20 diff
(96.5 %id)
BE541277 cervix .b 36 to 710 1 to 709       657/734
(89 %)
60 diff
(91.9 %id)
TI_151793533   .b 36 to 583 146 to 696       551/982
(56 %)
16 diff
(98.4 %id)
CN405299 embryonic stem cells, cell lines H1, H7, andH9 .b 37 to 644 1 to 608       608/608
(100 %)
0 diff
(100 %id)
TI_57193531   .b 37 to 764 67 to 791       725/740
(97 %)
15 diff
(98.0 %id)
TI_154034157   .b 37 to 944 975 to 87   AAA   889/950
(93 %)
34 diff
(96.5 %id)
CN405089 embryonic stem cells, DMSO-treated H9 cellline .b 38 to 679 1 to 643       643/643
(100 %)
2 diff
(99.7 %id)
CN405158 embryonic stem cells, DMSO-treated H9 cellline .b 38 to 182 1 to 145       145/145
(100 %)
1 diff
(99.4 %id)
CN405160 embryonic stem cells, DMSO-treated H9 cellline .b 38 to 617 1 to 580       580/580
(100 %)
0 diff
(100 %id)
CN405182 embryonic stem cells, DMSO-treated H9 cellline .b 38 to 627 1 to 590       590/590
(100 %)
0 diff
(100 %id)
CN405205 embryonic stem cells, DMSO-treated H9 cellline .b 38 to 563 1 to 526       526/526
(100 %)
0 diff
(100 %id)
CN405264 embryonic stem cells, DMSO-treated H9 cellline .b 38 to 560 1 to 523       523/523
(100 %)
0 diff
(100 %id)
CN405283 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 38 to 686 1 to 649       649/649
(100 %)
1 diff
(99.9 %id)
CN405384 embryonic stem cells, DMSO-treated H9 cellline .b 38 to 679 1 to 642       642/642
(100 %)
0 diff
(100 %id)
CN405434 embryonic stem cells, DMSO-treated H9 cellline .b 38 to 667 1 to 631       631/631
(100 %)
2 diff
(99.7 %id)
CN405512 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 38 to 722 1 to 685       685/685
(100 %)
0 diff
(100 %id)
CN405597 embryonic stem cells, DMSO-treated H9 cellline .b 38 to 679 1 to 642       642/642
(100 %)
0 diff
(100 %id)
CN405627 embryonic stem cells, DMSO-treated H9 cellline .b 38 to 732 1 to 695       695/695
(100 %)
0 diff
(100 %id)
CN405657 embryonic stem cells, DMSO-treated H9 cellline .b 38 to 732 1 to 696       696/696
(100 %)
1 diff
(99.9 %id)
CN405668 embryonic stem cells, DMSO-treated H9 cellline .b 38 to 622 1 to 585       585/585
(100 %)
0 diff
(100 %id)
CN405674 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 38 to 679 1 to 642       642/642
(100 %)
0 diff
(100 %id)
CN405681 embryonic stem cells, DMSO-treated H9 cellline .b 38 to 614 1 to 577       577/577
(100 %)
0 diff
(100 %id)
CN405698 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 38 to 731 1 to 693       693/693
(100 %)
1 diff
(99.9 %id)
EC476697 Prostate .b 38 to 174 1 to 135       135/135
(100 %)
2 diff
(98.6 %id)
CN405266 embryonic stem cells, DMSO-treated H9 cellline .b 39 to 734 1 to 695       695/695
(100 %)
0 diff
(100 %id)
CN405648 embryonic stem cells, cell lines H1, H7, andH9 .b 39 to 706 1 to 668       668/668
(100 %)
0 diff
(100 %id)
BE256680 eye, retinoblastoma .b 39 to 574 1 to 537       537/537
(100 %)
0 diff
(100 %id)
BE279349 choriocarcinoma, placenta .b 39 to 596 1 to 558       558/558
(100 %)
0 diff
(100 %id)
BE279346 choriocarcinoma, placenta .b 39 to 634 1 to 596       596/596
(100 %)
0 diff
(100 %id)
BE295497 muscle, rhabdomyosarcoma .b 39 to 618 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BE296755 muscle, rhabdomyosarcoma .b 39 to 678 1 to 640       640/641
(99 %)
1 diff
(99.9 %id)
BE270263 Burkitt lymphoma, lymph .b 39 to 706 1 to 665       665/679
(97 %)
6 diff
(99.2 %id)
BE900474 choriocarcinoma, placenta .b 39 to 718 1 to 679       679/830
(81 %)
4 diff
(99.6 %id)
CN405302 embryonic stem cells, cell lines H1, H7, andH9 .b 40 to 216 1 to 177       177/177
(100 %)
3 diff
(98.4 %id)
BE251614 eye, retinoblastoma .b 40 to 673 1 to 632       632/632
(100 %)
3 diff
(99.6 %id)
BE255259 eye, retinoblastoma .b 40 to 696 1 to 657       657/658
(99 %)
1 diff
(99.9 %id)
BE295334 muscle, rhabdomyosarcoma .b 40 to 711 1 to 670       670/675
(99 %)
6 diff
(99.2 %id)
BE296929 muscle, rhabdomyosarcoma .b 40 to 563 1 to 524       524/524
(100 %)
0 diff
(100 %id)
BE396374 Burkitt lymphoma, lymph .b 40 to 739 1 to 700       700/896
(78 %)
9 diff
(99.0 %id)
BE907982 epithelioid carcinoma, Pancreas .b 40 to 401 1 to 363       363/677
(53 %)
3 diff
(99.6 %id)
CN405269 embryonic stem cells, cell lines H1, H7, andH9 .b 41 to 655 1 to 615       615/615
(100 %)
0 diff
(100 %id)
CN405474 embryonic stem cells, DMSO-treated H9 cellline .b 41 to 187 1 to 147       147/147
(100 %)
0 diff
(100 %id)
BE304614 adenocarcinoma cell line, colon .b 41 to 718 1 to 676       676/740
(91 %)
8 diff
(99.0 %id)
BE900511 choriocarcinoma, placenta .b 41 to 707 1 to 667       667/806
(82 %)
3 diff
(99.7 %id)
BM907504 large cell carcinoma, lung .b 41 to 944 939 to 17   AAA Submitted on the opposite strand 923/1020
(90 %)
24 diff
(97.7 %id)
BE257352 eye, retinoblastoma .b 43 to 638 1 to 596       596/596
(100 %)
0 diff
(100 %id)
TI_154010252   .b 43 to 944 1025 to 109   AAA   809/1019
(79 %)
30 diff
(97.1 %id)
CN405130 embryonic stem cells, DMSO-treated H9 cellline .b 44 to 654 1 to 611       611/611
(100 %)
0 diff
(100 %id)
BM423592 amelanotic melanoma, cell line, skin .b 44 to 944 961 to 41   AAA Submitted on the opposite strand 919/1049
(87 %)
28 diff
(97.4 %id)
CN405522 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 45 to 381 1 to 337       337/337
(100 %)
2 diff
(99.5 %id)
AW248188 lung, small cell carcinoma .b 47 to 570 9 to 532       524/532
(98 %)
7 diff
(98.7 %id)
BE254084 eye, retinoblastoma .b 47 to 569 1 to 523       523/523
(100 %)
0 diff
(100 %id)
BE396776 Burkitt lymphoma, lymph .b 47 to 617 1 to 571       571/571
(100 %)
0 diff
(100 %id)
BE407686 choriocarcinoma, placenta .b 47 to 739 1 to 689       689/714
(96 %)
8 diff
(98.9 %id)
BE513811 Burkitt lymphoma, lymph .b 47 to 693 1 to 647       645/654
(98 %)
2 diff
(99.7 %id)
TI_154143212   .b 47 to 660 89 to 705       617/779
(79 %)
15 diff
(98.1 %id)
CN405609 embryonic stem cells, cell lines H1, H7, andH9 .b 49 to 432 1 to 384       384/384
(100 %)
0 diff
(100 %id)
CN405632 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 49 to 499 1 to 451       451/451
(100 %)
0 diff
(100 %id)
BE871810 adenocarcinoma, colon .b 49 to 735 9 to 723       715/968
(73 %)
52 diff
(94.7 %id)
TI_154142725   .b 49 to 583 80 to 618       539/635
(84 %)
18 diff
(97.2 %id)
CN405464 embryonic stem cells, DMSO-treated H9 cellline .b 50 to 455 1 to 406       406/406
(100 %)
0 diff
(100 %id)
AW406539 lymph .b 50 to 188 1 to 139       139/139
(100 %)
5 diff
(96.5 %id)
TI_154061506   .b 51 to 944 983 to 98   AAA   886/1002
(88 %)
30 diff
(97.1 %id)
TI_154142751   .b 51 to 660 78 to 693       616/634
(97 %)
25 diff
(96.1 %id)
TI_154143136   .b 51 to 625 74 to 649       576/576
(100 %)
16 diff
(97.3 %id)
TI_154144554   .b 51 to 646 78 to 673       596/596
(100 %)
25 diff
(95.9 %id)
TI_154145214   .b 51 to 543 77 to 569   AAA   493/873
(56 %)
24 diff
(97.3 %id)
CN405374 embryonic stem cells, DMSO-treated H9 cellline .b 52 to 451 1 to 400       400/400
(100 %)
0 diff
(100 %id)
CN405664 embryonic stem cells, DMSO-treated H9 cellline .b 52 to 457 1 to 406       406/406
(100 %)
0 diff
(100 %id)
TI_154035416   .b 52 to 946 967 to 91   tiling clone, AAA   877/940
(93 %)
27 diff
(97.2 %id)
TI_154148190   .b 53 to 690 105 to 743       639/674
(94 %)
50 diff
(92.6 %id)
CN405106 embryonic stem cells, DMSO-treated H9 cellline .b 54 to 439 1 to 386       386/386
(100 %)
0 diff
(100 %id)
CN405212 embryonic stem cells, DMSO-treated H9 cellline .b 54 to 191 1 to 138       138/138
(100 %)
0 diff
(100 %id)
CN405385 embryonic stem cells, DMSO-treated H9 cellline .b 54 to 603 1 to 550       550/550
(100 %)
0 diff
(100 %id)
CN405405 embryonic stem cells, DMSO-treated H9 cellline .b 54 to 441 1 to 388       388/388
(100 %)
0 diff
(100 %id)
CN405447 embryonic stem cells, DMSO-treated H9 cellline .b 54 to 630 1 to 577       577/577
(100 %)
0 diff
(100 %id)
CN405504 embryonic stem cells, DMSO-treated H9 cellline .b 54 to 455 1 to 402       402/402
(100 %)
0 diff
(100 %id)
CN405529 embryonic stem cells, DMSO-treated H9 cellline .b 54 to 654 1 to 601       601/601
(100 %)
0 diff
(100 %id)
CN405703 embryonic stem cells, DMSO-treated H9 cellline .b 54 to 452 1 to 399       399/399
(100 %)
0 diff
(100 %id)
TI_154144889   .b 54 to 685 86 to 717       632/638
(99 %)
18 diff
(97.2 %id)
BY995737   .b 55 to 699 46 to 691       646/691
(93 %)
7 diff
(99.0 %id)
CN405280 embryonic stem cells, DMSO-treated H9 cellline .b 56 to 451 1 to 396       396/396
(100 %)
0 diff
(100 %id)
CN405056 embryonic stem cells, cell lines H1, H7, andH9 .b 59 to 162 1 to 104       104/104
(100 %)
0 diff
(100 %id)
BE267832 Burkitt lymphoma, lymph .b 59 to 608 1 to 550       550/550
(100 %)
0 diff
(100 %id)
TI_154141393   .b 59 to 526 80 to 547       468/468
(100 %)
4 diff
(99.2 %id)
TI_154143869.
matches multiple genes
  .b 59 to 576 86 to 602     also hits gene RPS2P46 517/522
(99 %)
8 diff
(98.5 %id)
CN405427 embryonic stem cells, DMSO-treated H9 cellline .b 60 to 460 1 to 401       401/401
(100 %)
0 diff
(100 %id)
TI_154101788   .b 61 to 944 928 to 60   AAA   869/942
(92 %)
29 diff
(97.0 %id)
AI568435.
matches multiple genes
anaplastic oligodendroglioma, brain .b 63 to 158 96 to 1     also hits gene RPS2P5, RPS2P7, RPS2P55 96/96
(100 %)
0 diff
(100 %id)
CN405054 embryonic stem cells, DMSO-treated H9 cellline .b 64 to 538 1 to 475       475/475
(100 %)
0 diff
(100 %id)
CN405636 embryonic stem cells, DMSO-treated H9 cellline .b 64 to 734 1 to 671       671/678
(98 %)
1 diff
(99.9 %id)
CN405097 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 66 to 734 1 to 670       670/671
(99 %)
2 diff
(99.8 %id)
TI_154141805   .b 66 to 708 79 to 728       650/707
(91 %)
24 diff
(96.7 %id)
AA853163.
matches multiple genes
Bone, Hip .b 67 to 328 44 to 301     also hits gene RPS2P5 258/301
(85 %)
7 diff
(97.7 %id)
BQ942857 large cell carcinoma, lung .b 68 to 944 922 to 41   AAA Submitted on the opposite strand 882/888
(99 %)
15 diff
(98.4 %id)
TI_154062331   .b 68 to 944 929 to 61   AAA   869/958
(90 %)
31 diff
(96.8 %id)
TI_154147766   .b 68 to 729 80 to 743       664/664
(100 %)
4 diff
(99.4 %id)
BQ648095 hepatocellular carcinoma, cell line, Liver .b 71 to 944 910 to 35   AAA Submitted on the opposite strand 876/877
(99 %)
15 diff
(98.3 %id)
TI_154113123   .b 72 to 944 952 to 88   AAA   865/967
(89 %)
19 diff
(98.1 %id)
BM313570 Pancreas, Purified pancreatic islet .b 73 to 496 1 to 424       424/424
(100 %)
0 diff
(100 %id)
TI_154107126   .b 73 to 944 944 to 84   AAA   861/949
(90 %)
24 diff
(97.5 %id)
BM824694.
matches multiple genes
Ascites, stomach .b 77 to 235 1 to 159     also hits gene RPS2P5, RPS2P55 159/159
(100 %)
0 diff
(100 %id)
TI_59387655   .b 88 to 803 100 to 816       717/718
(99 %)
10 diff
(98.7 %id)
BM563109 astrocytoma grade IV, cell line, brain .b 93 to 942 1 to 851       851/1038
(81 %)
5 diff
(99.6 %id)
EC563799.
matches multiple genes
Prostate .b 102 to 224 1 to 123     also hits gene RPS2P5 123/123
(100 %)
0 diff
(100 %id)
BP384461 pancreatic islet .b 113 to 612 500 to 1       500/500
(100 %)
0 diff
(100 %id)
EC537999 Prostate .b 146 to 239 1 to 94       94/108
(87 %)
1 diff
(99.1 %id)
TI_154061915   .b 151 to 944 880 to 94   AAA   789/970
(81 %)
13 diff
(98.7 %id)
TI_154131921   .b 152 to 944 878 to 94   AAA   787/963
(81 %)
16 diff
(98.4 %id)
TI_154141996   .b 156 to 777 92 to 710       619/621
(99 %)
19 diff
(97.0 %id)
TI_154144444   .b 177 to 733 79 to 635       557/567
(98 %)
11 diff
(98.1 %id)
TI_154102345   .b 178 to 946 840 to 80   AAA   761/767
(99 %)
23 diff
(97.1 %id)
TI_154122428   .b 201 to 944 831 to 89   AAA   743/1026
(72 %)
8 diff
(99.3 %id)
TI_149296783   .b 205 to 944 826 to 90   AAA   737/777
(94 %)
14 diff
(98.2 %id)
TI_154030207   .b 205 to 944 817 to 80   AAA   738/979
(75 %)
2 diff
(99.8 %id)
TI_154044906   .b 205 to 944 821 to 85   AAA   737/971
(75 %)
8 diff
(99.2 %id)
TI_154052383   .b 205 to 944 824 to 94   AAA   731/912
(80 %)
12 diff
(98.7 %id)
TI_154061624   .b 205 to 944 829 to 91   AAA   739/956
(77 %)
2 diff
(99.8 %id)
TI_154062730   .b 205 to 944 830 to 93   AAA   738/1001
(73 %)
8 diff
(99.3 %id)
TI_154100717   .b 205 to 944 827 to 90   AAA   738/806
(91 %)
10 diff
(98.8 %id)
TI_154101431   .b 205 to 946 826 to 84   AAA   743/815
(91 %)
13 diff
(98.5 %id)
TI_154129284   .b 205 to 944 821 to 84   AAA   738/996
(74 %)
6 diff
(99.4 %id)
TI_154141833   .b 208 to 784 79 to 661       583/767
(76 %)
9 diff
(98.9 %id)
BM824868 Ascites, stomach .b 209 to 723 1 to 515       515/515
(100 %)
0 diff
(100 %id)
TI_154044418   .b 210 to 944 801 to 80   AAA   722/895
(80 %)
18 diff
(98.0 %id)
TI_154047914   .b 211 to 944 822 to 89   AAA   734/987
(74 %)
3 diff
(99.7 %id)
TI_154144219   .b 216 to 734 86 to 605       520/529
(98 %)
10 diff
(98.2 %id)
TI_149294499   .b 218 to 944 797 to 84   AAA   714/792
(90 %)
23 diff
(97.1 %id)
TI_154123597   .b 222 to 944 812 to 93   AAA   720/954
(75 %)
8 diff
(99.2 %id)
TI_154101464   .b 223 to 944 782 to 62   AAA   721/808
(89 %)
6 diff
(99.3 %id)
TI_154100169   .b 231 to 944 798 to 87   AAA   712/713
(99 %)
3 diff
(99.6 %id)
TI_149277602   .b 234 to 944 800 to 88   AAA   713/713
(100 %)
4 diff
(99.5 %id)
BM680007 eye, fetal eye .b 234 to 944 729 to 19   AAA   711/711
(100 %)
1 diff
(99.9 %id)
TI_149277324   .b 235 to 944 792 to 85   AAA   708/708
(100 %)
3 diff
(99.6 %id)
TI_154099595   .b 235 to 944 794 to 87   AAA   708/709
(99 %)
7 diff
(99.1 %id)
TI_154099691   .b 239 to 944 798 to 94   AAA   705/707
(99 %)
9 diff
(98.8 %id)
TI_154018846   .b 240 to 944 806 to 105   AAA   702/705
(99 %)
6 diff
(99.2 %id)
TI_154024454   .b 243 to 944 782 to 83   AAA   700/701
(99 %)
4 diff
(99.5 %id)
TI_154099582   .b 249 to 946 780 to 85   AAA   696/697
(99 %)
3 diff
(99.6 %id)
BI084937 epidermoid carcinoma, cell line, salivary gland .b 262 to 896 634 to 1   fully sequenced,   634/634
(100 %)
3 diff
(99.6 %id)
TI_154022032   .b 262 to 944 769 to 88   AAA   682/682
(100 %)
2 diff
(99.8 %id)
BQ322949 colon_est .b 263 to 698 436 to 1       436/436
(100 %)
4 diff
(99.1 %id)
TI_154019426   .b 263 to 944 779 to 99   AAA   681/682
(99 %)
2 diff
(99.8 %id)
BQ082744 stomach .b 268 to 736 1 to 469       469/469
(100 %)
0 diff
(100 %id)
CN405550 embryonic stem cells, DMSO-treated H9 cellline .b 271 to 679 1 to 409       409/409
(100 %)
0 diff
(100 %id)
TI_154042915   .b 274 to 944 761 to 93   AAA   669/947
(70 %)
2 diff
(99.8 %id)
BM682043 eye, fetal eye .b 276 to 944 685 to 19   AAA   667/667
(100 %)
3 diff
(99.6 %id)
BM678663 eye, fetal eye .b 288 to 946 677 to 19   AAA   659/662
(99 %)
1 diff
(99.9 %id)
BM677627 eye, fetal eye .b 288 to 944 673 to 19   AAA   655/658
(99 %)
3 diff
(99.6 %id)
BQ354586.
matches multiple genes
head_neck .b 290 to 632 369 to 29     also hits gene RPS2P46 341/369
(92 %)
0 diff
(100 %id)
BM759068 Ascites, stomach .b 290 to 880 1 to 591       591/591
(100 %)
0 diff
(100 %id)
BM782785 Ascites, stomach .b 290 to 881 1 to 592       592/592
(100 %)
0 diff
(100 %id)
EC520907.
matches multiple genes
Prostate .b 291 to 387 1 to 96     also hits gene RPS2P46 96/96
(100 %)
1 diff
(99.0 %id)
TI_149277807   .b 291 to 944 732 to 85   AAA   648/664
(97 %)
7 diff
(99.0 %id)
TI_149278230   .b 291 to 944 729 to 79   AAA   651/674
(96 %)
4 diff
(99.5 %id)
BQ323038 colon_est .b 293 to 704 415 to 3       413/415
(99 %)
1 diff
(99.8 %id)
CR608202 HeLa cells Cot 25-normalized .b 294 to 944 1 to 651       651/651
(100 %)
0 diff
(100 %id)
EC445371.
matches multiple genes
Prostate .b 297 to 391 1 to 93     also hits gene RPS2P46 93/93
(100 %)
2 diff
(97.9 %id)
EC540556.
matches multiple genes
Prostate .b 297 to 397 1 to 99     also hits gene RPS2P46 99/99
(100 %)
7 diff
(93.0 %id)
EC547477.
matches multiple genes
Prostate .b 297 to 391 1 to 93     also hits gene RPS2P46 93/93
(100 %)
2 diff
(97.9 %id)
EC495703.
matches multiple genes
Prostate .b 298 to 394 1 to 96     also hits gene RPS2P46 96/96
(100 %)
1 diff
(99.0 %id)
EC540504.
matches multiple genes
Prostate .b 299 to 397 1 to 97     also hits gene RPS2P46 97/97
(100 %)
1 diff
(99.0 %id)
EC541057.
matches multiple genes
Prostate .b 299 to 393 1 to 94     also hits gene RPS2P46 94/97
(96 %)
2 diff
(98.0 %id)
EC480775.
matches multiple genes
Prostate .b 303 to 400 1 to 96     also hits gene RPS2P46 96/97
(98 %)
5 diff
(94.9 %id)
TI_57192259   .b 305 to 805 52 to 551       500/824
(60 %)
3 diff
(99.7 %id)
TI_159694275   .b 313 to 944 729 to 98   AAA   632/969
(65 %)
0 diff
(100 %id)
AA557788 Prostate, prostatic intraepithelial neoplasia - highgrade .b 317 to 734 1 to 418       418/418
(100 %)
0 diff
(100 %id)
TI_154146123   .b 322 to 844 74 to 605       532/866
(61 %)
23 diff
(97.4 %id)
BG875188 breast .b 331 to 656 326 to 1       326/326
(100 %)
3 diff
(99.1 %id)
BM671997 eye, fetal eye .b 332 to 944 629 to 19   fully sequenced, AAA   611/611
(100 %)
0 diff
(100 %id)
BF175578 blood .b 340 to 485 1 to 145       145/147
(98 %)
4 diff
(97.3 %id)
TI_154007833   .b 340 to 944 691 to 87   AAA   605/952
(63 %)
0 diff
(100 %id)
BY995249   .b 341 to 944 651 to 48   AAA Submitted on the opposite strand 604/604
(100 %)
0 diff
(100 %id)
BG938536 Bone, Hip .b 342 to 923 582 to 1       582/582
(100 %)
0 diff
(100 %id)
EC580216 Prostate .b 347 to 443 96 to 1       96/98
(97 %)
1 diff
(99.0 %id)
EC462289 Prostate .b 348 to 446 1 to 98       98/98
(100 %)
6 diff
(93.9 %id)
TI_151740220   .b 351 to 944 712 to 118   AAA   595/873
(68 %)
5 diff
(99.5 %id)
AB065088   .b 359 to 945 1 to 587   AAA   587/587
(100 %)
0 diff
(100 %id)
BQ319234 colon .b 362 to 626 266 to 2       265/266
(99 %)
0 diff
(100 %id)
BF175497 blood .b 367 to 568 1 to 206       206/206
(100 %)
9 diff
(95.7 %id)
BG874728 breast .b 376 to 728 392 to 40       353/399
(88 %)
3 diff
(99.3 %id)
BQ301989.
matches multiple genes
breast .b 376 to 734 378 to 22     also hits gene RPS2P46 357/385
(92 %)
2 diff
(99.5 %id)
BM707984 eye, RPE and Choroid .b 378 to 928 1 to 551       551/551
(100 %)
0 diff
(100 %id)
AW673921 cervical carcinoma cell line, cervix .b 383 to 944 562 to 1       562/562
(100 %)
0 diff
(100 %id)
EC577711.
matches multiple genes
Prostate .b 428 to 522 1 to 95     also hits gene RPS2P46 95/95
(100 %)
5 diff
(94.8 %id)
AW245122 lung, small cell carcinoma .b 434 to 944 521 to 11   fully sequenced, AAA   511/511
(100 %)
0 diff
(100 %id)
EC481380.
matches multiple genes
Prostate .b 476 to 566 12 to 101     also hits gene RPS2P46 90/101
(89 %)
6 diff
(94.1 %id)
EC466174 Prostate .b 483 to 585 1 to 98       98/98
(100 %)
6 diff
(93.9 %id)
EC444183 Prostate .b 486 to 583 1 to 98       98/98
(100 %)
0 diff
(100 %id)
EC463823 Prostate .b 501 to 594 1 to 94       94/94
(100 %)
0 diff
(100 %id)
EC529679 Prostate .b 501 to 594 1 to 94       94/94
(100 %)
0 diff
(100 %id)
EC446974 Prostate .b 503 to 594 1 to 90       90/90
(100 %)
2 diff
(97.8 %id)
EC515029 Prostate .b 507 to 590 1 to 84       84/84
(100 %)
0 diff
(100 %id)
EC565224 Prostate .b 508 to 606 1 to 96       96/96
(100 %)
3 diff
(96.9 %id)
EC463931 Prostate .b 514 to 611 1 to 98       98/98
(100 %)
3 diff
(97.0 %id)
EC524757 Prostate .b 514 to 611 1 to 96       96/96
(100 %)
5 diff
(94.8 %id)
EC506243 Prostate .b 515 to 612 97 to 3       95/97
(97 %)
2 diff
(98.0 %id)
EC477087 Prostate .b 523 to 618 1 to 94       94/94
(100 %)
2 diff
(97.9 %id)
EC568894 Prostate .b 523 to 615 1 to 96       96/96
(100 %)
3 diff
(96.9 %id)
EC549176 Prostate .b 530 to 628 1 to 96       96/96
(100 %)
5 diff
(94.8 %id)
EC545140 Prostate .b 538 to 614 19 to 96       78/96
(81 %)
9 diff
(90.7 %id)
EC539089 Prostate .b 539 to 634 1 to 91       91/91
(100 %)
5 diff
(94.6 %id)
EC453295 Prostate .b 542 to 635 1 to 91       91/91
(100 %)
3 diff
(96.8 %id)
EC507204 Prostate .b 544 to 638 1 to 92       92/92
(100 %)
3 diff
(96.8 %id)
EC469007 Prostate .b 545 to 638 1 to 91       91/91
(100 %)
3 diff
(96.8 %id)
EC497901 Prostate .b 545 to 633 9 to 96       88/96
(91 %)
6 diff
(93.8 %id)
EC510646 Prostate .b 545 to 626 13 to 93       81/98
(82 %)
11 diff
(88.8 %id)
EC513166 Prostate .b 552 to 648 1 to 96       96/96
(100 %)
3 diff
(96.9 %id)
EC573094 Prostate .b 555 to 644 12 to 99       88/99
(88 %)
7 diff
(93.0 %id)
BG983061 colon_normal .b 558 to 673 126 to 10       117/145
(80 %)
0 diff
(100 %id)
EC578570 Prostate .b 558 to 648 2 to 92       91/92
(98 %)
6 diff
(93.5 %id)
EC556346 Prostate .b 560 to 648 1 to 89       89/89
(100 %)
0 diff
(100 %id)
EC537968 Prostate .b 562 to 649 88 to 1       88/93
(94 %)
1 diff
(99.0 %id)
EC570724 Prostate .b 562 to 647 86 to 1       86/92
(93 %)
1 diff
(99.0 %id)
DW458651 Liver .b 564 to 692 18 to 153       136/153
(88 %)
6 diff
(96.1 %id)
EC489138 Prostate .b 566 to 638 72 to 1       72/87
(82 %)
4 diff
(95.5 %id)
EC494030 Prostate .b 566 to 658 1 to 93       93/93
(100 %)
2 diff
(97.9 %id)
EC505961 Prostate .b 566 to 634 68 to 1       68/83
(81 %)
4 diff
(95.2 %id)
EC518838 Prostate .b 566 to 649 85 to 2       84/94
(89 %)
0 diff
(100 %id)
EC576899 Prostate .b 566 to 656 91 to 1       91/92
(98 %)
0 diff
(100 %id)
EC570603 Prostate .b 569 to 638 5 to 93       89/93
(95 %)
56 diff
(39.8 %id)
EC445797 Prostate .b 570 to 662 93 to 1       93/93
(100 %)
0 diff
(100 %id)
EC489469 Prostate .b 570 to 662 93 to 1       93/93
(100 %)
0 diff
(100 %id)
EC533789 Prostate .b 570 to 654 8 to 96       89/96
(92 %)
6 diff
(93.8 %id)
EC449179 Prostate .b 571 to 662 1 to 92       92/92
(100 %)
0 diff
(100 %id)
EC547360 Prostate .b 572 to 647 74 to 1       74/88
(84 %)
2 diff
(97.8 %id)
EC489277 Prostate .b 573 to 662 88 to 1       88/91
(96 %)
2 diff
(97.9 %id)
EC495891 Prostate .b 575 to 667 1 to 92       92/92
(100 %)
1 diff
(99.0 %id)
EC577472 Prostate .b 575 to 665 1 to 91       91/91
(100 %)
0 diff
(100 %id)
EC497308 Prostate .b 577 to 667 1 to 91       91/91
(100 %)
0 diff
(100 %id)
EC508592 Prostate .b 583 to 668 88 to 3       86/88
(97 %)
0 diff
(100 %id)
EC556101 Prostate .b 583 to 671 90 to 2       89/90
(98 %)
0 diff
(100 %id)
EC524999.
matches multiple genes
Prostate .b 586 to 668 1 to 83     also hits gene RPS2P46 83/83
(100 %)
0 diff
(100 %id)
EC462635.
matches multiple genes
Prostate .b 587 to 674 1 to 88     also hits gene RPS2P46 88/88
(100 %)
0 diff
(100 %id)
EC491132.
matches multiple genes
Prostate .b 587 to 674 1 to 88     also hits gene RPS2P46 88/88
(100 %)
0 diff
(100 %id)
EC509061.
matches multiple genes
Prostate .b 589 to 675 1 to 87     also hits gene RPS2P46 87/87
(100 %)
0 diff
(100 %id)
EC541180.
matches multiple genes
Prostate .b 590 to 668 1 to 78     also hits gene RPS2P46 78/78
(100 %)
1 diff
(98.8 %id)
EC475628.
matches multiple genes
Prostate .b 591 to 668 1 to 78     also hits gene RPS2P46 78/78
(100 %)
0 diff
(100 %id)
EC577583.
matches multiple genes
Prostate .b 595 to 683 1 to 89     also hits gene RPS2P46 89/89
(100 %)
0 diff
(100 %id)
EC491390.
matches multiple genes
Prostate .b 597 to 680 1 to 84     also hits gene RPS2P46 84/84
(100 %)
0 diff
(100 %id)
EC451622.
matches multiple genes
Prostate .b 598 to 685 88 to 1     also hits gene RPS2P46 88/88
(100 %)
0 diff
(100 %id)
EC451964.
matches multiple genes
Prostate .b 598 to 685 88 to 1     also hits gene RPS2P46 88/88
(100 %)
0 diff
(100 %id)
EC509896.
matches multiple genes
Prostate .b 598 to 685 88 to 1     also hits gene RPS2P46 88/88
(100 %)
0 diff
(100 %id)
EC583079.
matches multiple genes
Prostate .b 598 to 685 88 to 1     also hits gene RPS2P46 88/88
(100 %)
0 diff
(100 %id)
EC560232.
matches multiple genes
Prostate .b 600 to 688 1 to 89     also hits gene RPS2P46 89/89
(100 %)
0 diff
(100 %id)
EC513429.
matches multiple genes
Prostate .b 603 to 688 1 to 86     also hits gene RPS2P46 86/86
(100 %)
0 diff
(100 %id)
EC470874.
matches multiple genes
Prostate .b 606 to 691 1 to 85     also hits gene RPS2P5, RPS2P20, RPS2P46 85/85
(100 %)
4 diff
(95.3 %id)
EC539957.
matches multiple genes
Prostate .b 607 to 688 1 to 82     also hits gene RPS2P5, RPS2P20, RPS2P46 82/82
(100 %)
0 diff
(100 %id)
EC446776.
matches multiple genes
Prostate .b 609 to 688 1 to 80     also hits gene RPS2P5, RPS2P20, RPS2P46 80/80
(100 %)
0 diff
(100 %id)
EC542579.
matches multiple genes
Prostate .b 609 to 688 10 to 89     also hits gene RPS2P5, RPS2P20, RPS2P46 80/89
(89 %)
7 diff
(92.2 %id)
EC474889.
matches multiple genes
Prostate .b 613 to 697 1 to 85   tiling clone, also hits gene RPS2P5, RPS2P20, RPS2P46 85/85
(100 %)
0 diff
(100 %id)
EC532859.
matches multiple genes
Prostate .b 616 to 697 1 to 82     also hits gene RPS2P5, RPS2P20, RPS2P46 82/82
(100 %)
0 diff
(100 %id)
EC466963.
matches multiple genes
Prostate .b 620 to 709 1 to 90     also hits gene RPS2P5, RPS2P46 90/90
(100 %)
0 diff
(100 %id)
EC496960.
matches multiple genes
Prostate .b 620 to 709 1 to 90     also hits gene RPS2P5, RPS2P46 90/90
(100 %)
0 diff
(100 %id)
EC498092.
matches multiple genes
Prostate .b 620 to 706 1 to 87     also hits gene RPS2P5, RPS2P46 87/87
(100 %)
0 diff
(100 %id)
AA099216 colon, tumor .b 620 to 944 332 to 2       331/366
(90 %)
7 diff
(98.1 %id)
EC495689.
matches multiple genes
Prostate .b 621 to 707 1 to 87     also hits gene RPS2P5, RPS2P46 87/88
(98 %)
3 diff
(96.6 %id)
EC510102.
matches multiple genes
Prostate .b 621 to 709 1 to 89     also hits gene RPS2P5, RPS2P46 89/89
(100 %)
2 diff
(97.8 %id)
EC568925.
matches multiple genes
Prostate .b 621 to 707 1 to 87     also hits gene RPS2P5, RPS2P46 87/88
(98 %)
3 diff
(96.6 %id)
EC532882.
matches multiple genes
Prostate .b 622 to 709 1 to 88     also hits gene RPS2P5, RPS2P46 88/88
(100 %)
2 diff
(97.8 %id)
EC468868.
matches multiple genes
Prostate .b 627 to 696 1 to 70     also hits gene RPS2P5, RPS2P20, RPS2P46 70/70
(100 %)
0 diff
(100 %id)
EC540150.
matches multiple genes
Prostate .b 630 to 709 1 to 80     also hits gene RPS2P5, RPS2P46 80/80
(100 %)
0 diff
(100 %id)
EC556568.
matches multiple genes
Prostate .b 630 to 718 5 to 92     also hits gene RPS2P5, RPS2P7, RPS2P46 88/92
(95 %)
6 diff
(93.5 %id)
EC474625.
matches multiple genes
Prostate .b 631 to 714 1 to 84     also hits gene RPS2P5, RPS2P46 84/84
(100 %)
0 diff
(100 %id)
EC489191.
matches multiple genes
Prostate .b 631 to 714 1 to 84     also hits gene RPS2P5, RPS2P46 84/84
(100 %)
0 diff
(100 %id)
EC562964.
matches multiple genes
Prostate .b 632 to 712 8 to 88     also hits gene RPS2P5, RPS2P46 81/88
(92 %)
6 diff
(93.2 %id)
EC575592.
matches multiple genes
Prostate .b 634 to 706 1 to 73     also hits gene RPS2P5, RPS2P46 73/73
(100 %)
0 diff
(100 %id)
EC524235.
matches multiple genes
Prostate .b 635 to 721 1 to 87     also hits gene RPS2P5, RPS2P46 87/87
(100 %)
0 diff
(100 %id)
EC451914.
matches multiple genes
Prostate .b 636 to 709 12 to 85     also hits gene RPS2P5, RPS2P46 74/85
(87 %)
6 diff
(93.0 %id)
EC504423.
matches multiple genes
Prostate .b 637 to 726 1 to 90     also hits gene RPS2P5, RPS2P46 90/90
(100 %)
0 diff
(100 %id)
EC448129.
matches multiple genes
Prostate .b 638 to 727 1 to 90     also hits gene RPS2P5, RPS2P7, RPS2P46 90/90
(100 %)
0 diff
(100 %id)
EC498701.
matches multiple genes
Prostate .b 643 to 721 1 to 78     also hits gene RPS2P5, RPS2P7, RPS2P46 78/83
(93 %)
2 diff
(97.6 %id)
ES313377 beard hair, skin .b 686 to 935 1 to 250       250/250
(100 %)
0 diff
(100 %id)
CN405542 embryonic stem cells, DMSO-treated H9 cellline .b 703 to 944 1 to 242   AAA   242/242
(100 %)
0 diff
(100 %id)
L07393 retinal pigment epithelium .b 706 to 944 240 to 2     Submitted on the opposite strand 239/240
(99 %)
0 diff
(100 %id)
AA740154 2 pooled tumors (clear cell type), Kidney .b 717 to 944 244 to 17   AAA   228/228
(100 %)
0 diff
(100 %id)
AI869087 Prostate .b 728 to 944 227 to 11   AAA   217/217
(100 %)
0 diff
(100 %id)
AA969518 2 pooled tumors (clear cell type), Kidney .b 754 to 944 208 to 18   AAA   191/191
(100 %)
0 diff
(100 %id)
AW248035.
matches multiple genes
lung, small cell carcinoma .b 757 to 944 198 to 11   AAA also hits gene LOC113230 188/188
(100 %)
0 diff
(100 %id)
H49859.
matches multiple genes
brain .b 765 to 857 93 to 1     also hits gene RPS2P5 93/98
(94 %)
0 diff
(100 %id)
EC484529 Prostate .b 819 to 913 100 to 6       95/100
(95 %)
0 diff
(100 %id)
CA413440 Chondrosarcoma Grade II, Left Pelvis .b 822 to 944 141 to 19   AAA   123/123
(100 %)
0 diff
(100 %id)
EC501607 Prostate .b 827 to 918 99 to 8       92/99
(92 %)
0 diff
(100 %id)
BQ334159 marrow .b 828 to 937 112 to 6       107/112
(95 %)
0 diff
(100 %id)
BQ435094 leiomyosarcoma, uterus .b 855 to 944 1 to 90   AAA   90/90
(100 %)
0 diff
(100 %id)
BE903800 choriocarcinoma, placenta .c 1 to 846 2 to 832 D3L D4T A5P G6V A7Q ... tiling clone,   832/942
(88 %)
38 diff
(96.0 %id)
BE280864 choriocarcinoma, placenta .c 17 to 665 1 to 648       646/649
(99 %)
12 diff
(98.2 %id)
AV761187 bone marrow .c 69 to 483 19 to 432       414/433
(95 %)
9 diff
(98.0 %id)
CD616015   .c 70 to 267 201 to 4       198/220
(90 %)
7 diff
(96.9 %id)
EC455002 Prostate .c 70 to 166 97 to 1       97/112
(86 %)
5 diff
(95.6 %id)
BE790167 large cell carcinoma, lung .c 70 to 852 14 to 787       774/808
(95 %)
25 diff
(97.0 %id)
BE740796 adenocarcinoma cell line, ovary .c 70 to 854 39 to 819   tiling clone,   781/821
(95 %)
24 diff
(97.1 %id)
BM455817 lymph, lymphoma, cell line .c 70 to 856 24 to 814   tiling clone, AAA   791/814
(97 %)
13 diff
(98.5 %id)
BU170391 eye, retinoblastoma .c 70 to 853 36 to 831       796/896
(88 %)
27 diff
(97.0 %id)
CA774675 Pancreas, Purified pancreatic islet .c 70 to 823 754 to 1   tiling clone,   754/766
(98 %)
11 diff
(98.6 %id)
TI_59382289   .c 70 to 772 115 to 815       701/712
(98 %)
31 diff
(95.7 %id)
AV763076 bone marrow .c 70 to 851 23 to 800       757/1250
(60 %)
77 diff
(93.9 %id)
AV760167 bone marrow .c 70 to 741 23 to 693       671/693
(96 %)
26 diff
(96.3 %id)
AV763477 bone marrow .c 70 to 713 23 to 667       645/697
(92 %)
26 diff
(96.3 %id)
AV764021 bone marrow .c 70 to 831 2 to 761       760/766
(99 %)
27 diff
(96.5 %id)
AV762944 bone marrow .c 70 to 798 8 to 729       722/739
(97 %)
19 diff
(97.5 %id)
DW427010 Liver .c 73 to 339 14 to 280       267/280
(95 %)
9 diff
(96.8 %id)
BG386506 adenocarcinoma cell line, colon .c 78 to 816 22 to 763   tiling clone,   742/830
(89 %)
17 diff
(98.0 %id)
CF128174 Chondrosarcoma Lung Metastasis cell lines, lung .c 78 to 633 1 to 556       556/556
(100 %)
4 diff
(99.3 %id)
AV760589 bone marrow .c 78 to 845 31 to 796   AAA   766/796
(96 %)
23 diff
(97.2 %id)
AV763799 bone marrow .c 78 to 772 31 to 722       692/1231
(56 %)
15 diff
(98.8 %id)
AV764589 bone marrow .c 78 to 832 31 to 776       746/1297
(57 %)
33 diff
(97.5 %id)
AV762684 bone marrow .c 78 to 759 31 to 712       682/713
(95 %)
13 diff
(98.2 %id)
AV758922 bone marrow .c 78 to 766 31 to 716       686/717
(95 %)
37 diff
(94.9 %id)
AV761308 bone marrow .c 78 to 798 35 to 752       717/754
(95 %)
27 diff
(96.5 %id)
AV760148 bone marrow .c 78 to 759 33 to 709       677/710
(95 %)
20 diff
(97.2 %id)
AV764485 bone marrow .c 78 to 825 31 to 772       742/773
(95 %)
28 diff
(96.4 %id)
AV762692 bone marrow .c 78 to 813 32 to 764       733/767
(95 %)
24 diff
(96.9 %id)
AV763523 bone marrow .c 78 to 808 33 to 760       728/765
(95 %)
32 diff
(95.9 %id)
BF104142 embryonal carcinoma, testis .c 79 to 629 16 to 557       542/1255
(43 %)
13 diff
(99.0 %id)
TI_57231702   .c 79 to 849 29 to 801   tiling clone,   773/801
(96 %)
6 diff
(99.3 %id)
CN405393 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 84 to 483 1 to 400       400/400
(100 %)
0 diff
(100 %id)
AW248129 lung, small cell carcinoma .d 1 to 394 10 to 403       394/403
(97 %)
0 diff
(100 %id)
BF312307 brain, neuroblastoma .d 1 to 753 2 to 752       751/889
(84 %)
13 diff
(98.6 %id)
BG323965 Kidney, renal cell adenocarcinoma .d 1 to 832 2 to 838 L203W G204A N205T F206S A207P ... tiling clone,   837/1152
(72 %)
32 diff
(97.3 %id)
BQ049688 lymph, lymphoma, cell line .d 2 to 750 1 to 755       755/1103
(68 %)
17 diff
(98.5 %id)
CN484453.
matches multiple genes
eye .d 3 to 595 1 to 593     Suspected internal deletion, this clone was ignored, also hits gene RPS2P55 593/593
(100 %)
0 diff
(100 %id)
BM424284 amelanotic melanoma, cell line, skin .d 3 to 843 1 to 844 D3Y G204X D241G tiling clone, AAA   845/844
(100 %)
14 diff
(98.4 %id)
CR995936 T-Lymphocytes .d 4 to 214 1 to 212       212/215
(98 %)
4 diff
(98.2 %id)
CN482083 eye .d 6 to 595 1 to 590       590/590
(100 %)
0 diff
(100 %id)
BU195952 epithelioid carcinoma, Pancreas .d 7 to 453 1 to 453       453/843
(53 %)
8 diff
(99.1 %id)
BQ441922 embryonal carcinoma, cell line, testis .d 9 to 687 2 to 683       682/878
(77 %)
11 diff
(98.8 %id)
CD106909 brain, Pituitary .d 11 to 784 1 to 772       777/802
(96 %)
9 diff
(98.9 %id)
BM824214 Ascites, stomach .d 14 to 497 1 to 484       484/484
(100 %)
1 diff
(99.8 %id)
CR985380 T-Lymphocytes .d 23 to 753 1 to 731       731/731
(100 %)
0 diff
(100 %id)
CN405148 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 24 to 723 1 to 699       699/699
(100 %)
1 diff
(99.9 %id)
CN405394 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 24 to 738 1 to 717       717/717
(100 %)
2 diff
(99.8 %id)
BE796683 lung, small cell carcinoma .d 25 to 567 1 to 543       543/579
(93 %)
1 diff
(99.9 %id)
BE260172 brain, neuroblastoma .d 26 to 596 1 to 573       573/573
(100 %)
2 diff
(99.7 %id)
BE559588 Burkitt lymphoma, lymph .d 26 to 783 1 to 754       754/963
(78 %)
16 diff
(98.4 %id)
BE745510 adenocarcinoma cell line, ovary .d 26 to 839 1 to 797       797/903
(88 %)
22 diff
(97.6 %id)
AV760532 bone marrow .d 146 to 833 1 to 688   tiling clone,   688/697
(98 %)
2 diff
(99.8 %id)
CD389715 embryonic trophoblasts, made from WA01 stemcells .e 1 to 616 19 to 645   tiling clone,   629/824
(76 %)
26 diff
(96.9 %id)
BI257862 cervical carcinoma cell line, cervix .e 14 to 470 1 to 457   tiling clone,   457/457
(100 %)
1 diff
(99.8 %id)
BQ422775 melanotic melanoma, skin .e 19 to 701 1 to 693       693/943
(73 %)
16 diff
(98.4 %id)
CN421734 embryonic stem cells, cell lines H1, H7, andH9 .e 20 to 384 36 to 400       366/400
(91 %)
8 diff
(98.0 %id)
AW662954 2 pooled high-grade transitional celltumors, genitourinary tract .e 20 to 288 9 to 276       268/268
(100 %)
7 diff
(97.4 %id)
BG179459 adenocarcinoma, cell line, Prostate .e 21 to 803 1 to 764 M19N N21E R22P G23R G24W ...     764/949
(80 %)
16 diff
(98.4 %id)
BU857273 adenocarcinoma, cell line, breast .e 210 to 834 1 to 625   tiling clone, AAA   625/625
(100 %)
2 diff
(99.7 %id)
AW628371 2 pooled high-grade transitional celltumors, genitourinary tract .e 376 to 834 461 to 3       459/461
(99 %)
10 diff
(97.9 %id)
CN421738 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 1 to 719 6 to 724   tiling clone,   724/724
(100 %)
5 diff
(99.4 %id)
BE746721 adenocarcinoma cell line, ovary .f 77 to 879 1 to 794       794/929
(85 %)
24 diff
(97.5 %id)
BE744631 adenocarcinoma cell line, ovary .f 218 to 952 1 to 727       727/987
(73 %)
17 diff
(98.3 %id)
BU526589 epidermoid carcinoma, cell line, lung .f 327 to 1210 911 to 22   tiling clone, AAA Submitted on the opposite strand 890/938
(94 %)
11 diff
(98.9 %id)
BG573969 breast, mammary adenocarcinoma, cell line .f 408 to 1210 1 to 805       805/832
(96 %)
18 diff
(97.9 %id)
BI093928 cervix .f 458 to 1153 1 to 692       692/693
(99 %)
5 diff
(99.3 %id)
CD104529 Pooled-Skin .f 586 to 1210 1 to 624       624/629
(99 %)
6 diff
(99.1 %id)
EC583745 Prostate .f 721 to 814 94 to 1       94/94
(100 %)
0 diff
(100 %id)
BG987537 head_neck .f 791 to 999 25 to 233       209/233
(89 %)
6 diff
(97.5 %id)
BG987533 head_neck .f 793 to 999 17 to 215       199/215
(92 %)
6 diff
(97.3 %id)
EC475874 Prostate .f 793 to 892 100 to 1       100/100
(100 %)
0 diff
(100 %id)
AJ609432   .f 805 to 937 1 to 133       133/133
(100 %)
0 diff
(100 %id)
NR_002327.1   .f 805 to 937 1 to 133   RefSeq,   133/133
(100 %)
0 diff
(100 %id)
AA769794   .f 820 to 1210 400 to 10       391/400
(97 %)
0 diff
(100 %id)
BF804807 colon_ins .f 858 to 1174 327 to 13     Submitted on the opposite strand 315/327
(96 %)
0 diff
(100 %id)
BQ940311 leiomyosarcoma, uterus .f 889 to 1210 1 to 322       322/356
(90 %)
1 diff
(99.8 %id)
AI874045 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f 934 to 1199 280 to 13   AAA   268/268
(100 %)
2 diff
(99.3 %id)
BI160453 epithelioid carcinoma cell line, Pancreas .g 1 to 869 1 to 862   tiling clone,   862/887
(97 %)
19 diff
(97.9 %id)
BG746883 adenocarcinoma cell line, colon .g 172 to 923 1 to 752 exact     752/959
(78 %)
5 diff
(99.5 %id)
CN421746 embryonic stem cells, cell lines H1, H7, andH9 .g 173 to 688 12 to 527       519/527
(98 %)
6 diff
(98.9 %id)
BQ645959 hepatocellular carcinoma, cell line, Liver .g 176 to 919 2 to 754 G176X D196H T204P S206V P207S ...     753/967
(77 %)
25 diff
(97.5 %id)
CD048091 embryonic stem cells, WA01, passage 38 .g 178 to 838 45 to 716       672/977
(68 %)
27 diff
(97.3 %id)
CR983979 T-Lymphocytes .g 179 to 565 1 to 387       387/387
(100 %)
1 diff
(99.8 %id)
BG828959 muscle, rhabdomyosarcoma .g 180 to 923 1 to 747       747/805
(92 %)
15 diff
(98.2 %id)
AV692492 hepatocellular carcinoma .g 181 to 826 1 to 646       646/648
(99 %)
10 diff
(98.5 %id)
CN421714 embryonic stem cells, DMSO-treated H9 cellline .g 191 to 782 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
CN421713 embryonic stem cells, DMSO-treated H9 cellline .g 225 to 772 1 to 548       548/550
(99 %)
1 diff
(99.9 %id)
CN421743 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 267 to 786 1 to 520       520/520
(100 %)
1 diff
(99.9 %id)
CR601170 placenta .g 268 to 924 1 to 657   tiling clone,   657/657
(100 %)
0 diff
(100 %id)
BX458636 placenta .g 268 to 924 1 to 656       656/656
(100 %)
6 diff
(99.1 %id)
AV763202.
matches multiple genes
bone marrow .g 313 to 757 1 to 443   tiling clone, also hits gene RPS2P5 443/444
(99 %)
5 diff
(98.9 %id)
BU598558 mixed (pool of 40 RNAs) .h 1 to 642 1 to 658   tiling clone,   658/888
(74 %)
29 diff
(96.8 %id)
BG613390 embryonal carcinoma, testis .h 3 to 687 1 to 682   tiling clone,   682/683
(99 %)
9 diff
(98.7 %id)
BG500638 adenocarcinoma, Prostate .h 4 to 723 1 to 718   tiling clone,   718/718
(100 %)
7 diff
(99.1 %id)
EC569144 Prostate .h 75 to 701 1 to 91   tiling clone,   91/91
(100 %)
5 diff
(94.6 %id)
BU959270 mixed (pool of 40 RNAs) .i 1 to 694 4 to 699 G2R F3G A215V tiling clone,   696/825
(84 %)
13 diff
(98.5 %id)
CD247542 embryonic stem cells, WA01, passage 38 .j 1 to 638 18 to 658 I81T G168R K176T P181S K183Q ... tiling clone,   643/985
(65 %)
31 diff
(96.9 %id)
CD249364 embryonic stem cells, WA01, passage 38 .j 3 to 861 17 to 879 exact tiling clone,   863/879
(98 %)
15 diff
(98.3 %id)
CR975220 T-Lymphocytes .j 15 to 593 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
CN405350 embryonic stem cells, cell lines H1, H7, andH9 .j 16 to 597 13 to 594       582/594
(97 %)
1 diff
(99.9 %id)
CN421748 embryonic stem cells, DMSO-treated H9 cellline .j 16 to 758 9 to 752 exact tiling clone,   744/752
(98 %)
3 diff
(99.7 %id)
CN421712 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 20 to 665 1 to 646 exact     646/646
(100 %)
1 diff
(99.9 %id)
CR983791 T-Lymphocytes .j 21 to 750 1 to 730 exact     730/730
(100 %)
1 diff
(99.9 %id)
BM842544 lymph node, stomach .k 1 to 591 1 to 591   tiling clone,   591/591
(100 %)
2 diff
(99.7 %id)
BM820279 stomach .k 1 to 410 1 to 410       410/410
(100 %)
0 diff
(100 %id)
AB065089   .k 14 to 1199 1 to 1186 exact tiling clone, AAA   1186/1186
(100 %)
1 diff
(100.0 %id)
BG336062 choriocarcinoma, placenta .k 14 to 807 1 to 782       782/932
(83 %)
32 diff
(96.6 %id)
BE735295 choriocarcinoma, placenta .k 16 to 860 33 to 873 L107*     841/986
(85 %)
24 diff
(97.6 %id)
TI_57191047   .k 30 to 568 101 to 637       537/537
(100 %)
3 diff
(99.5 %id)
BE744059 adenocarcinoma cell line, ovary .k 34 to 752 1 to 748       709/924
(76 %)
59 diff
(93.7 %id)
BE731973 choriocarcinoma, placenta .k 34 to 784 1 to 757       757/759
(99 %)
30 diff
(96.1 %id)
BE268032 Burkitt lymphoma, lymph .k 42 to 595 1 to 554       554/554
(100 %)
0 diff
(100 %id)
TI_154141302   .k 43 to 542 80 to 579       500/500
(100 %)
2 diff
(99.6 %id)
BE296621 muscle, rhabdomyosarcoma .k 45 to 578 1 to 534       534/534
(100 %)
0 diff
(100 %id)
BM457818 lymph, lymphoma, cell line .k 198 to 1066 1 to 872 exact     872/905
(96 %)
22 diff
(97.6 %id)
BG911237 anaplastic oligodendroglioma with 1p/19qloss, brain .k 199 to 852 1 to 655 R44L R46P G47R R48P G49R ...     655/656
(99 %)
7 diff
(99.0 %id)
BQ068939 brain, neuroblastoma, cell line .k 201 to 931 1 to 736 R196T     736/1015
(72 %)
26 diff
(97.5 %id)
BG682033 skin, squamous cell carcinoma .k 204 to 989 1 to 789       789/842
(93 %)
21 diff
(97.6 %id)
CR998228 T-Lymphocytes .k 205 to 835 1 to 631       631/635
(99 %)
2 diff
(99.7 %id)
CN421728 embryonic stem cells, DMSO-treated H9 cellline .k 214 to 856 1 to 643       643/643
(100 %)
1 diff
(99.9 %id)
BE795164 lung, small cell carcinoma .k 216 to 1087 1 to 860       835/860
(97 %)
30 diff
(96.6 %id)
BE792941 lung, small cell carcinoma .k 219 to 962 1 to 744       744/744
(100 %)
8 diff
(99.0 %id)
BQ073541 epidermoid carcinoma, cell line, lung .k 302 to 1173 902 to 19   tiling clone, AAA Submitted on the opposite strand 882/1028
(85 %)
14 diff
(98.7 %id)
AV763604 bone marrow .k 336 to 989 1 to 644       644/698
(92 %)
45 diff
(93.6 %id)
AV758961 bone marrow .k 336 to 1061 1 to 725       725/739
(98 %)
22 diff
(97.1 %id)
BU160661 melanotic melanoma, skin .k 383 to 1199 20 to 839   AAA   820/839
(97 %)
15 diff
(98.3 %id)
CN421711 embryonic stem cells, cell lines H1, H7, andH9 .k 402 to 1112 18 to 726       709/726
(97 %)
7 diff
(99.1 %id)
BE298442 muscle, rhabdomyosarcoma .k 408 to 1067 1 to 657       657/659
(99 %)
7 diff
(99.0 %id)
BF569361 Kidney, renal carcinoma (ascites) .k 417 to 1199 1 to 783   fully sequenced, AAA   783/783
(100 %)
15 diff
(98.1 %id)
AI440306 B-cell, chronic lymphotic leukemia .k 750 to 1199 453 to 5       449/453
(99 %)
0 diff
(100 %id)
BG676931 skin, squamous cell carcinoma .k 766 to 1196 1 to 432   AAA   432/1024
(42 %)
5 diff
(99.6 %id)
BF570157 Kidney, renal carcinoma (ascites) .k 768 to 1158 427 to 37   fully sequenced,   391/427
(91 %)
1 diff
(99.8 %id)
AW467498 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .k 772 to 1199 437 to 10       428/437
(97 %)
3 diff
(99.4 %id)
AI476028 colon, moderately-differentiated adenocarcinoma .k 820 to 1199 389 to 10       380/391
(97 %)
1 diff
(99.8 %id)
BM809397 amelanotic melanoma, cell line, skin .l 1 to 762 30 to 792 G6V K65R Q120H R121G tiling clone, AAA   767/792
(96 %)
13 diff
(98.4 %id)
D11893 Liver .l 522 to 762 1 to 241   tiling clone,   241/244
(98 %)
1 diff
(99.6 %id)
BG333221 large cell carcinoma, lung .m 1 to 822 1 to 818 L89* tiling clone,   818/819
(99 %)
12 diff
(98.6 %id)
BE541805 cervix .m 547 to 911 1 to 365   tiling clone,   365/366
(99 %)
1 diff
(99.8 %id)
BP873175 embryonal kidney .n 1 to 582 1 to 581   tiling clone,   581/581
(100 %)
5 diff
(99.2 %id)
CR624847 T cells (Jurkat cell line) .n 196 to 1743 1 to 1548 exact tiling clone,   1548/1548
(100 %)
0 diff
(100 %id)
BX426565 T cells (Jurkat cell line) .n 196 to 936 1 to 739   fully sequenced,   739/739
(100 %)
9 diff
(98.8 %id)
BX426564 T cells (Jurkat cell line) .n 906 to 1743 822 to 1 R8V A9P G10A Q11S R12A ... fully sequenced,   822/822
(100 %)
4 diff
(99.6 %id)
CR996341 T-Lymphocytes .o 1 to 653 1 to 653 exact tiling clone,   653/653
(100 %)
1 diff
(99.9 %id)
BG282897 adenocarcinoma, cell line, Prostate .o 3 to 740 1 to 738 L107*     738/738
(100 %)
25 diff
(96.7 %id)
DR157078 human embryonic stem cells differentiated toan early endodermal cell type .o 3 to 680 1 to 678 exact     678/678
(100 %)
1 diff
(99.9 %id)
BC063011 Blood, adult leukocytes .o 6 to 1248 1 to 1243 exact tiling clone, available from MGC, AAA   1243/1243
(100 %)
1 diff
(100.0 %id)
BI910102 leukocyte .o 6 to 831 1 to 829 L107* available from MGC,   829/829
(100 %)
12 diff
(98.6 %id)
TI_57235859   .o 6 to 831 37 to 865 L107*     830/865
(95 %)
18 diff
(98.0 %id)
CN421732 embryonic stem cells, DMSO-treated H9 cellline .o 11 to 452 1 to 442   tiling clone,   442/442
(100 %)
0 diff
(100 %id)
CN421741 embryonic stem cells, cell lines H1, H7, andH9 .o 13 to 760 1 to 749       749/749
(100 %)
2 diff
(99.8 %id)
CT004387 T-Lymphocytes .o 16 to 559 1 to 544       544/555
(98 %)
2 diff
(99.7 %id)
BE263765 lung, small cell carcinoma .o 21 to 712 1 to 687       687/718
(95 %)
10 diff
(98.7 %id)
CT002357 T-Lymphocytes .o 23 to 566 1 to 544       544/546
(99 %)
2 diff
(99.7 %id)
CN421739 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o 24 to 658 1 to 635       635/635
(100 %)
1 diff
(99.9 %id)
CN421735 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .o 35 to 588 1 to 555       555/555
(100 %)
2 diff
(99.7 %id)
CN421747 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o 277 to 906 1 to 628       628/628
(100 %)
3 diff
(99.6 %id)
BE936551 nervous_tumor .o 291 to 593 15 to 317       303/319
(94 %)
4 diff
(98.8 %id)
T68031 Liver .o 389 to 808 22 to 442       421/449
(93 %)
20 diff
(95.6 %id)
EC568655 Prostate .o 477 to 590 114 to 2       113/114
(99 %)
0 diff
(100 %id)
EC471629 Prostate .o 484 to 590 107 to 2       106/109
(97 %)
0 diff
(100 %id)
T67880 Liver .o 867 to 1222 356 to 1       356/402
(88 %)
17 diff
(95.8 %id)
CN405677 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .p 1 to 387 1 to 387   tiling clone,   387/387
(100 %)
3 diff
(99.3 %id)
AA160712 Pancreas .p 163 to 710 1 to 533 G9X G13A P14A G15W G16P ... tiling clone, fully sequenced,   533/533
(100 %)
14 diff
(97.4 %id)
AA159508 Pancreas .p 680 to 1075 407 to 13   tiling clone, fully sequenced, AAA   395/395
(100 %)
2 diff
(99.5 %id)
CX781018 human embryonic stem cells .q 1 to 822 1 to 822   tiling clone,   822/822
(100 %)
1 diff
(99.9 %id)
BE546891 cervical carcinoma cell line, cervix .q 133 to 904 216 to 773       605/1069
(56 %)
55 diff
(94.9 %id)
CN405671 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .q 160 to 916 1 to 756   tiling clone,   756/756
(100 %)
8 diff
(99.0 %id)
BE839316 prostate_normal .r 1 to 217 13 to 229   tiling clone,   217/239
(90 %)
13 diff
(94.6 %id)
AA935577 carcinoid, lung .r 54 to 532 1 to 478   tiling clone, Submitted on the opposite strand 478/510
(93 %)
18 diff
(96.5 %id)
BU656684 blood .s 1 to 538 10 to 547 G2R F3G tiling clone,   538/547
(98 %)
8 diff
(98.6 %id)
BG166801 hypernephroma, cell line, Kidney .s 46 to 779 9 to 738   tiling clone,   730/740
(98 %)
13 diff
(98.3 %id)
AA302398 aorta .s 461 to 756 1 to 297   tiling clone,   297/297
(100 %)
1 diff
(99.7 %id)
BQ058867 lymph, lymphoma, cell line .t 1 to 822 6 to 830   tiling clone,   830/1065
(77 %)
12 diff
(98.9 %id)
CX873208 embryonic stem .t 1 to 809 4 to 812       812/812
(100 %)
2 diff
(99.8 %id)
CN421742 embryonic stem cells, DMSO-treated H9 cellline .t 7 to 488 1 to 482   tiling clone,   482/482
(100 %)
0 diff
(100 %id)
CR976761 T-Lymphocytes .t 269 to 906 1 to 638 W134X R136X R139X A140X tiling clone,   638/638
(100 %)
3 diff
(99.6 %id)
BI461449 testis .u-u 1 to 848 1 to 852   tiling clone,   852/852
(100 %)
32 diff
(96.3 %id)
BI465034 testis .u-u 1 to 731 1 to 732       732/732
(100 %)
14 diff
(98.1 %id)
BP872944 embryonal kidney .u-u 6 to 588 1 to 582       582/582
(100 %)
7 diff
(98.8 %id)
BG900732 cartilage .u-u 19 to 563 50 to 594       545/594
(91 %)
6 diff
(99.0 %id)
CN421716 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .u-u 20 to 649 1 to 630   tiling clone,   630/630
(100 %)
1 diff
(99.9 %id)
BG755736 B-cells, primary B-cells from tonsils (cell line) .u-u 20 to 678 1 to 664       664/664
(100 %)
21 diff
(96.9 %id)
CR980642 T-Lymphocytes .u-u 20 to 432 1 to 413       413/413
(100 %)
1 diff
(99.8 %id)
BG740809 skin .u-u 26 to 657 1 to 631       631/631
(100 %)
3 diff
(99.6 %id)
DB272097 uterus .u-u 257 to 799 2 to 545   capped   544/544
(100 %)
5 diff
(99.1 %id)
DA680790 ovary .u-u 261 to 821 2 to 562   tiling clone, capped   561/561
(100 %)
2 diff
(99.7 %id)
BF768861 epid_tumor .u-u 593 to 1107 516 to 5   tiling clone, Submitted on the opposite strand 512/516
(99 %)
0 diff
(100 %id)
BF892430 marrow .u-u 683 to 915 1 to 238       238/238
(100 %)
21 diff
(91.2 %id)
AW865451 stomach_normal .u-u 876 to 1024 155 to 8   tiling clone,   148/157
(94 %)
0 diff
(100 %id)
AW865586 stomach_normal .u-u 876 to 991 123 to 8       116/125
(92 %)
0 diff
(100 %id)
AI940403 colon .u-u 1037 to 1156 11 to 132   tiling clone,   122/132
(92 %)
6 diff
(95.5 %id)
CK430926 eye, lacrimal gland .u-u 1038 to 1554 1 to 517   tiling clone,   517/517
(100 %)
6 diff
(98.9 %id)
BI061094 uterus_tumor .u-u 1326 to 1547 223 to 1   tiling clone,   223/223
(100 %)
7 diff
(96.9 %id)
NR_002326.1   .u-u 1726 to 1859 1 to 134   RefSeq, tiling clone,   134/134
(100 %)
0 diff
(100 %id)
Y11158   .u-u 1726 to 1859 1 to 134       134/134
(100 %)
0 diff
(100 %id)
CN405303 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells Gene RPS2andSNORA64andSNORA10, variant not shown         Submitted on the opposite strand    
DB510857 testis Gene RPS2andSNORA64andSNORA10, variant not shown         Submitted on the opposite strand    
DB555641 hypothalamus Gene RPS2andSNORA64andSNORA10, variant not shown         Submitted on the opposite strand    
AA179581   Gene RPS2andSNORA64andSNORA10, variant not shown         Submitted on the opposite strand    
AA828902 ovary Gene RPS2andSNORA64andSNORA10, variant not shown         This clone was ignored    
BG575938 breast, mammary adenocarcinoma, cell line Gene RPS2andSNORA64andSNORA10, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BQ717405 sympathetic trunk Gene RPS2andSNORA64andSNORA10, variant not shown              
AA853162 Bone, Hip Gene RPS2andSNORA64andSNORA10, variant not shown         This clone was ignored    
523 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI